JPH08131162A - Gene for coding phosphoenolpyruvic carboxylase - Google Patents
Gene for coding phosphoenolpyruvic carboxylaseInfo
- Publication number
- JPH08131162A JPH08131162A JP27133894A JP27133894A JPH08131162A JP H08131162 A JPH08131162 A JP H08131162A JP 27133894 A JP27133894 A JP 27133894A JP 27133894 A JP27133894 A JP 27133894A JP H08131162 A JPH08131162 A JP H08131162A
- Authority
- JP
- Japan
- Prior art keywords
- ala
- leu
- arg
- asp
- thr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract description 32
- 239000013598 vector Substances 0.000 claims abstract description 28
- 239000012634 fragment Substances 0.000 claims abstract description 22
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 4
- 108091000041 Phosphoenolpyruvate Carboxylase Proteins 0.000 claims description 90
- 108020004414 DNA Proteins 0.000 claims description 39
- 230000000694 effects Effects 0.000 claims description 20
- 238000012258 culturing Methods 0.000 claims description 14
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 239000002773 nucleotide Substances 0.000 claims description 7
- 125000003729 nucleotide group Chemical group 0.000 claims description 7
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 4
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 2
- 230000035772 mutation Effects 0.000 claims 1
- 229920001184 polypeptide Polymers 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 abstract description 29
- 108090000790 Enzymes Proteins 0.000 abstract description 29
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 abstract description 24
- 241000589216 Komagataeibacter hansenii Species 0.000 abstract description 18
- 241000588724 Escherichia coli Species 0.000 abstract description 16
- 239000001569 carbon dioxide Substances 0.000 abstract description 12
- 229910002092 carbon dioxide Inorganic materials 0.000 abstract description 12
- 108091008146 restriction endonucleases Proteins 0.000 abstract description 10
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 9
- 239000013611 chromosomal DNA Substances 0.000 abstract description 5
- 238000012216 screening Methods 0.000 abstract description 5
- 238000007796 conventional method Methods 0.000 abstract description 4
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000002463 transducing effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 description 39
- 244000005700 microbiome Species 0.000 description 26
- 229940088598 enzyme Drugs 0.000 description 25
- 239000000243 solution Substances 0.000 description 19
- 235000018102 proteins Nutrition 0.000 description 17
- 102000004169 proteins and genes Human genes 0.000 description 17
- 210000004027 cell Anatomy 0.000 description 16
- 238000002360 preparation method Methods 0.000 description 15
- 239000002609 medium Substances 0.000 description 12
- 238000002523 gelfiltration Methods 0.000 description 9
- 150000001413 amino acids Chemical group 0.000 description 8
- 108010038633 aspartylglutamate Proteins 0.000 description 8
- 238000005119 centrifugation Methods 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 238000002835 absorbance Methods 0.000 description 7
- 229930029653 phosphoenolpyruvate Natural products 0.000 description 7
- 108010015796 prolylisoleucine Proteins 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- LVMUGODRNHFGRA-AVGNSLFASA-N Arg-Leu-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O LVMUGODRNHFGRA-AVGNSLFASA-N 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 6
- BVOVIGCHYNFJBZ-JXUBOQSCSA-N Thr-Leu-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O BVOVIGCHYNFJBZ-JXUBOQSCSA-N 0.000 description 6
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 6
- 108010005233 alanylglutamic acid Proteins 0.000 description 6
- 108010040030 histidinoalanine Proteins 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- 229920005654 Sephadex Polymers 0.000 description 5
- 239000012507 Sephadex™ Substances 0.000 description 5
- 239000012190 activator Substances 0.000 description 5
- 238000004440 column chromatography Methods 0.000 description 5
- 108020004707 nucleic acids Proteins 0.000 description 5
- 102000039446 nucleic acids Human genes 0.000 description 5
- 150000007523 nucleic acids Chemical class 0.000 description 5
- DTBNBXWJWCWCIK-UHFFFAOYSA-N phosphoenolpyruvic acid Chemical compound OC(=O)C(=C)OP(O)(O)=O DTBNBXWJWCWCIK-UHFFFAOYSA-N 0.000 description 5
- 239000013612 plasmid Substances 0.000 description 5
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- WQVFQXXBNHHPLX-ZKWXMUAHSA-N Ala-Ala-His Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1cnc[nH]1)C(O)=O WQVFQXXBNHHPLX-ZKWXMUAHSA-N 0.000 description 4
- QDRGPQWIVZNJQD-CIUDSAMLSA-N Ala-Arg-Gln Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(O)=O QDRGPQWIVZNJQD-CIUDSAMLSA-N 0.000 description 4
- OKIKVSXTXVVFDV-MMWGEVLESA-N Ala-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](C)N OKIKVSXTXVVFDV-MMWGEVLESA-N 0.000 description 4
- UHFUZWSZQKMDSX-DCAQKATOSA-N Arg-Leu-Asn Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N UHFUZWSZQKMDSX-DCAQKATOSA-N 0.000 description 4
- UGXVKHRDGLYFKR-CIUDSAMLSA-N Asn-Asp-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC(N)=O UGXVKHRDGLYFKR-CIUDSAMLSA-N 0.000 description 4
- 229920002271 DEAE-Sepharose Polymers 0.000 description 4
- 102000012410 DNA Ligases Human genes 0.000 description 4
- 108010061982 DNA Ligases Proteins 0.000 description 4
- KKCUFHUTMKQQCF-SRVKXCTJSA-N Glu-Arg-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O KKCUFHUTMKQQCF-SRVKXCTJSA-N 0.000 description 4
- CKOFNWCLWRYUHK-XHNCKOQMSA-N Glu-Asp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)N)C(=O)O CKOFNWCLWRYUHK-XHNCKOQMSA-N 0.000 description 4
- UMYZBHKAVTXWIW-GMOBBJLQSA-N Ile-Asp-Arg Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N UMYZBHKAVTXWIW-GMOBBJLQSA-N 0.000 description 4
- KAFOIVJDVSZUMD-UHFFFAOYSA-N Leu-Gln-Gln Natural products CC(C)CC(N)C(=O)NC(CCC(N)=O)C(=O)NC(CCC(N)=O)C(O)=O KAFOIVJDVSZUMD-UHFFFAOYSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- LZDIENNKWVXJMX-JYJNAYRXSA-N Phe-Arg-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC1=CC=CC=C1 LZDIENNKWVXJMX-JYJNAYRXSA-N 0.000 description 4
- 108010079005 RDV peptide Proteins 0.000 description 4
- DDRBQONWVBDQOY-GUBZILKMSA-N Val-Ala-Arg Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O DDRBQONWVBDQOY-GUBZILKMSA-N 0.000 description 4
- 108010070944 alanylhistidine Proteins 0.000 description 4
- 238000012870 ammonium sulfate precipitation Methods 0.000 description 4
- 108010013835 arginine glutamate Proteins 0.000 description 4
- 229940041514 candida albicans extract Drugs 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 108010078144 glutaminyl-glycine Proteins 0.000 description 4
- 230000000813 microbial effect Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- -1 peptone Chemical class 0.000 description 4
- 108010082795 phenylalanyl-arginyl-arginine Proteins 0.000 description 4
- 108010026333 seryl-proline Proteins 0.000 description 4
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 4
- 229920002554 vinyl polymer Polymers 0.000 description 4
- 239000012138 yeast extract Substances 0.000 description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
- 241000589220 Acetobacter Species 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 241000588722 Escherichia Species 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- KAFOIVJDVSZUMD-DCAQKATOSA-N Leu-Gln-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O KAFOIVJDVSZUMD-DCAQKATOSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 102000016943 Muramidase Human genes 0.000 description 3
- 108010014251 Muramidase Proteins 0.000 description 3
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 3
- 229920002873 Polyethylenimine Polymers 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 230000002934 lysing effect Effects 0.000 description 3
- 239000004325 lysozyme Substances 0.000 description 3
- 229960000274 lysozyme Drugs 0.000 description 3
- 235000010335 lysozyme Nutrition 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- KHPXUQMNIQBQEV-UHFFFAOYSA-N oxaloacetic acid Chemical compound OC(=O)CC(=O)C(O)=O KHPXUQMNIQBQEV-UHFFFAOYSA-N 0.000 description 3
- 239000008057 potassium phosphate buffer Substances 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- ZFXQNADNEBRERM-BJDJZHNGSA-N Ala-Ala-Pro-Pro Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 ZFXQNADNEBRERM-BJDJZHNGSA-N 0.000 description 2
- JBVSSSZFNTXJDX-YTLHQDLWSA-N Ala-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)N JBVSSSZFNTXJDX-YTLHQDLWSA-N 0.000 description 2
- SVBXIUDNTRTKHE-CIUDSAMLSA-N Ala-Arg-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O SVBXIUDNTRTKHE-CIUDSAMLSA-N 0.000 description 2
- KVWLTGNCJYDJET-LSJOCFKGSA-N Ala-Arg-His Chemical compound C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N KVWLTGNCJYDJET-LSJOCFKGSA-N 0.000 description 2
- SKHCUBQVZJHOFM-NAKRPEOUSA-N Ala-Arg-Ile Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O SKHCUBQVZJHOFM-NAKRPEOUSA-N 0.000 description 2
- NHCPCLJZRSIDHS-ZLUOBGJFSA-N Ala-Asp-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O NHCPCLJZRSIDHS-ZLUOBGJFSA-N 0.000 description 2
- FOWHQTWRLFTELJ-FXQIFTODSA-N Ala-Asp-Met Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCSC)C(=O)O)N FOWHQTWRLFTELJ-FXQIFTODSA-N 0.000 description 2
- VIGKUFXFTPWYER-BIIVOSGPSA-N Ala-Cys-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)O)N VIGKUFXFTPWYER-BIIVOSGPSA-N 0.000 description 2
- UQJUGHFKNKGHFQ-VZFHVOOUSA-N Ala-Cys-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)O)C(O)=O UQJUGHFKNKGHFQ-VZFHVOOUSA-N 0.000 description 2
- FVSOUJZKYWEFOB-KBIXCLLPSA-N Ala-Gln-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)N FVSOUJZKYWEFOB-KBIXCLLPSA-N 0.000 description 2
- LMFXXZPPZDCPTA-ZKWXMUAHSA-N Ala-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@H](C)N LMFXXZPPZDCPTA-ZKWXMUAHSA-N 0.000 description 2
- QHASENCZLDHBGX-ONGXEEELSA-N Ala-Gly-Phe Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 QHASENCZLDHBGX-ONGXEEELSA-N 0.000 description 2
- HUUOZYZWNCXTFK-INTQDDNPSA-N Ala-His-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N2CCC[C@@H]2C(=O)O)N HUUOZYZWNCXTFK-INTQDDNPSA-N 0.000 description 2
- PNALXAODQKTNLV-JBDRJPRFSA-N Ala-Ile-Ala Chemical compound C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O PNALXAODQKTNLV-JBDRJPRFSA-N 0.000 description 2
- NYDBKUNVSALYPX-NAKRPEOUSA-N Ala-Ile-Arg Chemical compound C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CCCN=C(N)N NYDBKUNVSALYPX-NAKRPEOUSA-N 0.000 description 2
- HQJKCXHQNUCKMY-GHCJXIJMSA-N Ala-Ile-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](C)N HQJKCXHQNUCKMY-GHCJXIJMSA-N 0.000 description 2
- GSHKMNKPMLXSQW-KBIXCLLPSA-N Ala-Ile-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](C)N GSHKMNKPMLXSQW-KBIXCLLPSA-N 0.000 description 2
- TZDNWXDLYFIFPT-BJDJZHNGSA-N Ala-Ile-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O TZDNWXDLYFIFPT-BJDJZHNGSA-N 0.000 description 2
- LXAARTARZJJCMB-CIQUZCHMSA-N Ala-Ile-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O LXAARTARZJJCMB-CIQUZCHMSA-N 0.000 description 2
- LBYMZCVBOKYZNS-CIUDSAMLSA-N Ala-Leu-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O LBYMZCVBOKYZNS-CIUDSAMLSA-N 0.000 description 2
- DPNZTBKGAUAZQU-DLOVCJGASA-N Ala-Leu-His Chemical compound C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N DPNZTBKGAUAZQU-DLOVCJGASA-N 0.000 description 2
- SOBIAADAMRHGKH-CIUDSAMLSA-N Ala-Leu-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O SOBIAADAMRHGKH-CIUDSAMLSA-N 0.000 description 2
- UWIQWPWWZUHBAO-ZLIFDBKOSA-N Ala-Leu-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)N)CC(C)C)C(O)=O)=CNC2=C1 UWIQWPWWZUHBAO-ZLIFDBKOSA-N 0.000 description 2
- MDNAVFBZPROEHO-DCAQKATOSA-N Ala-Lys-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O MDNAVFBZPROEHO-DCAQKATOSA-N 0.000 description 2
- MDNAVFBZPROEHO-UHFFFAOYSA-N Ala-Lys-Val Natural products CC(C)C(C(O)=O)NC(=O)C(NC(=O)C(C)N)CCCCN MDNAVFBZPROEHO-UHFFFAOYSA-N 0.000 description 2
- KYDYGANDJHFBCW-DRZSPHRISA-N Ala-Phe-Gln Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N KYDYGANDJHFBCW-DRZSPHRISA-N 0.000 description 2
- DHBKYZYFEXXUAK-ONGXEEELSA-N Ala-Phe-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=CC=C1 DHBKYZYFEXXUAK-ONGXEEELSA-N 0.000 description 2
- IHMCQESUJVZTKW-UBHSHLNASA-N Ala-Phe-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)CC1=CC=CC=C1 IHMCQESUJVZTKW-UBHSHLNASA-N 0.000 description 2
- FFZJHQODAYHGPO-KZVJFYERSA-N Ala-Pro-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N FFZJHQODAYHGPO-KZVJFYERSA-N 0.000 description 2
- DCVYRWFAMZFSDA-ZLUOBGJFSA-N Ala-Ser-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O DCVYRWFAMZFSDA-ZLUOBGJFSA-N 0.000 description 2
- OEVCHROQUIVQFZ-YTLHQDLWSA-N Ala-Thr-Ala Chemical compound C[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](C)C(O)=O OEVCHROQUIVQFZ-YTLHQDLWSA-N 0.000 description 2
- HCBKAOZYACJUEF-XQXXSGGOSA-N Ala-Thr-Gln Chemical compound N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CCC(N)=O)C(=O)O HCBKAOZYACJUEF-XQXXSGGOSA-N 0.000 description 2
- IOFVWPYSRSCWHI-JXUBOQSCSA-N Ala-Thr-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C)N IOFVWPYSRSCWHI-JXUBOQSCSA-N 0.000 description 2
- KUFVXLQLDHJVOG-SHGPDSBTSA-N Ala-Thr-Thr Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](C)N)O KUFVXLQLDHJVOG-SHGPDSBTSA-N 0.000 description 2
- RIPMDCIXRYWXSH-KNXALSJPSA-N Ala-Trp-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N3CCC[C@@H]3C(=O)O)N RIPMDCIXRYWXSH-KNXALSJPSA-N 0.000 description 2
- YEBZNKPPOHFZJM-BPNCWPANSA-N Ala-Tyr-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(O)=O YEBZNKPPOHFZJM-BPNCWPANSA-N 0.000 description 2
- LYILPUNCKACNGF-NAKRPEOUSA-N Ala-Val-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)N LYILPUNCKACNGF-NAKRPEOUSA-N 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- SGYSTDWPNPKJPP-GUBZILKMSA-N Arg-Ala-Arg Chemical compound NC(=N)NCCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O SGYSTDWPNPKJPP-GUBZILKMSA-N 0.000 description 2
- HULHGJZIZXCPLD-FXQIFTODSA-N Arg-Ala-Cys Chemical compound C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N HULHGJZIZXCPLD-FXQIFTODSA-N 0.000 description 2
- YFWTXMRJJDNTLM-LSJOCFKGSA-N Arg-Ala-His Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N YFWTXMRJJDNTLM-LSJOCFKGSA-N 0.000 description 2
- KGSJCPBERYUXCN-BPNCWPANSA-N Arg-Ala-Tyr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O KGSJCPBERYUXCN-BPNCWPANSA-N 0.000 description 2
- UXJCMQFPDWCHKX-DCAQKATOSA-N Arg-Arg-Glu Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(O)=O)C(O)=O UXJCMQFPDWCHKX-DCAQKATOSA-N 0.000 description 2
- AQPVUEJJARLJHB-BQBZGAKWSA-N Arg-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](N)CCCN=C(N)N AQPVUEJJARLJHB-BQBZGAKWSA-N 0.000 description 2
- HQIZDMIGUJOSNI-IUCAKERBSA-N Arg-Gly-Arg Chemical compound N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O HQIZDMIGUJOSNI-IUCAKERBSA-N 0.000 description 2
- SYAUZLVLXCDRSH-IUCAKERBSA-N Arg-Gly-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)N SYAUZLVLXCDRSH-IUCAKERBSA-N 0.000 description 2
- UPKMBGAAEZGHOC-RWMBFGLXSA-N Arg-His-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CCCN=C(N)N)N)C(=O)O UPKMBGAAEZGHOC-RWMBFGLXSA-N 0.000 description 2
- OKKMBOSPBDASEP-CYDGBPFRSA-N Arg-Ile-Met Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(O)=O OKKMBOSPBDASEP-CYDGBPFRSA-N 0.000 description 2
- YBZMTKUDWXZLIX-UWVGGRQHSA-N Arg-Leu-Gly Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O YBZMTKUDWXZLIX-UWVGGRQHSA-N 0.000 description 2
- UZGFHWIJWPUPOH-IHRRRGAJSA-N Arg-Leu-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N UZGFHWIJWPUPOH-IHRRRGAJSA-N 0.000 description 2
- OMKZPCPZEFMBIT-SRVKXCTJSA-N Arg-Met-Arg Chemical compound NC(=N)NCCC[C@H](N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O OMKZPCPZEFMBIT-SRVKXCTJSA-N 0.000 description 2
- ATABBWFGOHKROJ-GUBZILKMSA-N Arg-Pro-Ser Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O ATABBWFGOHKROJ-GUBZILKMSA-N 0.000 description 2
- URAUIUGLHBRPMF-NAKRPEOUSA-N Arg-Ser-Ile Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O URAUIUGLHBRPMF-NAKRPEOUSA-N 0.000 description 2
- WCZXPVPHUMYLMS-VEVYYDQMSA-N Arg-Thr-Asp Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O WCZXPVPHUMYLMS-VEVYYDQMSA-N 0.000 description 2
- XYOVHPDDWCEUDY-CIUDSAMLSA-N Asn-Ala-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O XYOVHPDDWCEUDY-CIUDSAMLSA-N 0.000 description 2
- QQEWINYJRFBLNN-DLOVCJGASA-N Asn-Ala-Phe Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 QQEWINYJRFBLNN-DLOVCJGASA-N 0.000 description 2
- ZZXMOQIUIJJOKZ-ZLUOBGJFSA-N Asn-Asn-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC(N)=O ZZXMOQIUIJJOKZ-ZLUOBGJFSA-N 0.000 description 2
- VYLVOMUVLMGCRF-ZLUOBGJFSA-N Asn-Asp-Ser Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O VYLVOMUVLMGCRF-ZLUOBGJFSA-N 0.000 description 2
- XMHFCUKJRCQXGI-CIUDSAMLSA-N Asn-Pro-Gln Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CC(=O)N)N)C(=O)N[C@@H](CCC(=O)N)C(=O)O XMHFCUKJRCQXGI-CIUDSAMLSA-N 0.000 description 2
- KRXIWXCXOARFNT-ZLUOBGJFSA-N Asp-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O KRXIWXCXOARFNT-ZLUOBGJFSA-N 0.000 description 2
- GBAWQWASNGUNQF-ZLUOBGJFSA-N Asp-Ala-Cys Chemical compound C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC(=O)O)N GBAWQWASNGUNQF-ZLUOBGJFSA-N 0.000 description 2
- PBVLJOIPOGUQQP-CIUDSAMLSA-N Asp-Ala-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O PBVLJOIPOGUQQP-CIUDSAMLSA-N 0.000 description 2
- IXIWEFWRKIUMQX-DCAQKATOSA-N Asp-Arg-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(O)=O IXIWEFWRKIUMQX-DCAQKATOSA-N 0.000 description 2
- FAEIQWHBRBWUBN-FXQIFTODSA-N Asp-Arg-Ser Chemical compound C(C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC(=O)O)N)CN=C(N)N FAEIQWHBRBWUBN-FXQIFTODSA-N 0.000 description 2
- UGIBTKGQVWFTGX-BIIVOSGPSA-N Asp-Asn-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)O)N)C(=O)O UGIBTKGQVWFTGX-BIIVOSGPSA-N 0.000 description 2
- CELPEWWLSXMVPH-CIUDSAMLSA-N Asp-Asp-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC(O)=O CELPEWWLSXMVPH-CIUDSAMLSA-N 0.000 description 2
- FTNVLGCFIJEMQT-CIUDSAMLSA-N Asp-Cys-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CC(=O)O)N FTNVLGCFIJEMQT-CIUDSAMLSA-N 0.000 description 2
- RSMIHCFQDCVVBR-CIUDSAMLSA-N Asp-Gln-Arg Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(O)=O)CCCNC(N)=N RSMIHCFQDCVVBR-CIUDSAMLSA-N 0.000 description 2
- LTXGDRFJRZSZAV-CIUDSAMLSA-N Asp-Glu-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)N LTXGDRFJRZSZAV-CIUDSAMLSA-N 0.000 description 2
- WSGVTKZFVJSJOG-RCOVLWMOSA-N Asp-Gly-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O WSGVTKZFVJSJOG-RCOVLWMOSA-N 0.000 description 2
- RNAQPBOOJRDICC-BPUTZDHNSA-N Asp-Met-Trp Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](CC(=O)O)N RNAQPBOOJRDICC-BPUTZDHNSA-N 0.000 description 2
- QJHOOKBAHRJPPX-QWRGUYRKSA-N Asp-Phe-Gly Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CC=CC=C1 QJHOOKBAHRJPPX-QWRGUYRKSA-N 0.000 description 2
- KRQFMDNIUOVRIF-KKUMJFAQSA-N Asp-Phe-His Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)NC(=O)[C@H](CC(=O)O)N KRQFMDNIUOVRIF-KKUMJFAQSA-N 0.000 description 2
- KOWYNSKRPUWSFG-IHPCNDPISA-N Asp-Phe-Trp Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)O)NC(=O)[C@H](CC(=O)O)N KOWYNSKRPUWSFG-IHPCNDPISA-N 0.000 description 2
- HJZLUGQGJWXJCJ-CIUDSAMLSA-N Asp-Pro-Gln Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(O)=O HJZLUGQGJWXJCJ-CIUDSAMLSA-N 0.000 description 2
- MNQMTYSEKZHIDF-GCJQMDKQSA-N Asp-Thr-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O MNQMTYSEKZHIDF-GCJQMDKQSA-N 0.000 description 2
- IWLZBRTUIVXZJD-OLHMAJIHSA-N Asp-Thr-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O IWLZBRTUIVXZJD-OLHMAJIHSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 108010090461 DFG peptide Proteins 0.000 description 2
- 206010059866 Drug resistance Diseases 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- HDUDGCZEOZEFOA-KBIXCLLPSA-N Gln-Ile-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](CCC(=O)N)N HDUDGCZEOZEFOA-KBIXCLLPSA-N 0.000 description 2
- MLSKFHLRFVGNLL-WDCWCFNPSA-N Gln-Leu-Thr Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MLSKFHLRFVGNLL-WDCWCFNPSA-N 0.000 description 2
- XQDGOJPVMSWZSO-SRVKXCTJSA-N Gln-Pro-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)N)N XQDGOJPVMSWZSO-SRVKXCTJSA-N 0.000 description 2
- WLRYGVYQFXRJDA-DCAQKATOSA-N Gln-Pro-Pro Chemical compound NC(=O)CC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 WLRYGVYQFXRJDA-DCAQKATOSA-N 0.000 description 2
- UTOQQOMEJDPDMX-ACZMJKKPSA-N Gln-Ser-Asp Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O UTOQQOMEJDPDMX-ACZMJKKPSA-N 0.000 description 2
- OKQLXOYFUPVEHI-CIUDSAMLSA-N Gln-Ser-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)N)N OKQLXOYFUPVEHI-CIUDSAMLSA-N 0.000 description 2
- HUWSBFYAGXCXKC-CIUDSAMLSA-N Glu-Ala-Met Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(O)=O HUWSBFYAGXCXKC-CIUDSAMLSA-N 0.000 description 2
- LTUVYLVIZHJCOQ-KKUMJFAQSA-N Glu-Arg-Phe Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O LTUVYLVIZHJCOQ-KKUMJFAQSA-N 0.000 description 2
- GCYFUZJHAXJKKE-KKUMJFAQSA-N Glu-Arg-Tyr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O GCYFUZJHAXJKKE-KKUMJFAQSA-N 0.000 description 2
- GZWOBWMOMPFPCD-CIUDSAMLSA-N Glu-Asp-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)N GZWOBWMOMPFPCD-CIUDSAMLSA-N 0.000 description 2
- PXHABOCPJVTGEK-BQBZGAKWSA-N Glu-Gln-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O PXHABOCPJVTGEK-BQBZGAKWSA-N 0.000 description 2
- YLJHCWNDBKKOEB-IHRRRGAJSA-N Glu-Glu-Phe Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O YLJHCWNDBKKOEB-IHRRRGAJSA-N 0.000 description 2
- PHONAZGUEGIOEM-GLLZPBPUSA-N Glu-Glu-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PHONAZGUEGIOEM-GLLZPBPUSA-N 0.000 description 2
- HPJLZFTUUJKWAJ-JHEQGTHGSA-N Glu-Gly-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O HPJLZFTUUJKWAJ-JHEQGTHGSA-N 0.000 description 2
- DVLZZEPUNFEUBW-AVGNSLFASA-N Glu-His-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CCC(=O)O)N DVLZZEPUNFEUBW-AVGNSLFASA-N 0.000 description 2
- WTMZXOPHTIVFCP-QEWYBTABSA-N Glu-Ile-Phe Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 WTMZXOPHTIVFCP-QEWYBTABSA-N 0.000 description 2
- ZHNHJYYFCGUZNQ-KBIXCLLPSA-N Glu-Ile-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CCC(O)=O ZHNHJYYFCGUZNQ-KBIXCLLPSA-N 0.000 description 2
- IRXNJYPKBVERCW-DCAQKATOSA-N Glu-Leu-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O IRXNJYPKBVERCW-DCAQKATOSA-N 0.000 description 2
- PAZQYODKOZHXGA-SRVKXCTJSA-N Glu-Pro-His Chemical compound N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1cnc[nH]1)C(O)=O PAZQYODKOZHXGA-SRVKXCTJSA-N 0.000 description 2
- ZKONLKQGTNVAPR-DCAQKATOSA-N Glu-Pro-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)N ZKONLKQGTNVAPR-DCAQKATOSA-N 0.000 description 2
- BKMOHWJHXQLFEX-IRIUXVKKSA-N Glu-Tyr-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CCC(=O)O)N)O BKMOHWJHXQLFEX-IRIUXVKKSA-N 0.000 description 2
- FGGKGJHCVMYGCD-UKJIMTQDSA-N Glu-Val-Ile Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O FGGKGJHCVMYGCD-UKJIMTQDSA-N 0.000 description 2
- OVSKVOOUFAKODB-UWVGGRQHSA-N Gly-Arg-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCN=C(N)N OVSKVOOUFAKODB-UWVGGRQHSA-N 0.000 description 2
- XUORRGAFUQIMLC-STQMWFEESA-N Gly-Arg-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)CN)O XUORRGAFUQIMLC-STQMWFEESA-N 0.000 description 2
- XLFHCWHXKSFVIB-BQBZGAKWSA-N Gly-Gln-Gln Chemical compound NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O XLFHCWHXKSFVIB-BQBZGAKWSA-N 0.000 description 2
- UFPXDFOYHVEIPI-BYPYZUCNSA-N Gly-Gly-Asp Chemical compound NCC(=O)NCC(=O)N[C@H](C(O)=O)CC(O)=O UFPXDFOYHVEIPI-BYPYZUCNSA-N 0.000 description 2
- OLPPXYMMIARYAL-QMMMGPOBSA-N Gly-Gly-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)CNC(=O)CN OLPPXYMMIARYAL-QMMMGPOBSA-N 0.000 description 2
- PAWIVEIWWYGBAM-YUMQZZPRSA-N Gly-Leu-Ala Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O PAWIVEIWWYGBAM-YUMQZZPRSA-N 0.000 description 2
- CCBIBMKQNXHNIN-ZETCQYMHSA-N Gly-Leu-Gly Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O CCBIBMKQNXHNIN-ZETCQYMHSA-N 0.000 description 2
- NNCSJUBVFBDDLC-YUMQZZPRSA-N Gly-Leu-Ser Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O NNCSJUBVFBDDLC-YUMQZZPRSA-N 0.000 description 2
- MIIVFRCYJABHTQ-ONGXEEELSA-N Gly-Leu-Val Chemical compound [H]NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O MIIVFRCYJABHTQ-ONGXEEELSA-N 0.000 description 2
- JYPCXBJRLBHWME-IUCAKERBSA-N Gly-Pro-Arg Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O JYPCXBJRLBHWME-IUCAKERBSA-N 0.000 description 2
- BMWFDYIYBAFROD-WPRPVWTQSA-N Gly-Pro-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)CN BMWFDYIYBAFROD-WPRPVWTQSA-N 0.000 description 2
- IRJWAYCXIYUHQE-WHFBIAKZSA-N Gly-Ser-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)CN IRJWAYCXIYUHQE-WHFBIAKZSA-N 0.000 description 2
- WNGHUXFWEWTKAO-YUMQZZPRSA-N Gly-Ser-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)CN WNGHUXFWEWTKAO-YUMQZZPRSA-N 0.000 description 2
- UIQGJYUEQDOODF-KWQFWETISA-N Gly-Tyr-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CN)CC1=CC=C(O)C=C1 UIQGJYUEQDOODF-KWQFWETISA-N 0.000 description 2
- RIYIFUFFFBIOEU-KBPBESRZSA-N Gly-Tyr-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CC=C(O)C=C1 RIYIFUFFFBIOEU-KBPBESRZSA-N 0.000 description 2
- GBYYQVBXFVDJPJ-WLTAIBSBSA-N Gly-Tyr-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)CN)O GBYYQVBXFVDJPJ-WLTAIBSBSA-N 0.000 description 2
- QIVPRLJQQVXCIY-HGNGGELXSA-N His-Ala-Gln Chemical compound C[C@H](NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](CCC(N)=O)C(O)=O QIVPRLJQQVXCIY-HGNGGELXSA-N 0.000 description 2
- FLUVGKKRRMLNPU-CQDKDKBSSA-N His-Ala-Phe Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O FLUVGKKRRMLNPU-CQDKDKBSSA-N 0.000 description 2
- MDBYBTWRMOAJAY-NHCYSSNCSA-N His-Asn-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC1=CN=CN1)N MDBYBTWRMOAJAY-NHCYSSNCSA-N 0.000 description 2
- LMMPTUVWHCFTOT-GARJFASQSA-N His-Asp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC2=CN=CN2)N)C(=O)O LMMPTUVWHCFTOT-GARJFASQSA-N 0.000 description 2
- IMCHNUANCIGUKS-SRVKXCTJSA-N His-Glu-Arg Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O IMCHNUANCIGUKS-SRVKXCTJSA-N 0.000 description 2
- HAPWZEVRQYGLSG-IUCAKERBSA-N His-Gly-Glu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O HAPWZEVRQYGLSG-IUCAKERBSA-N 0.000 description 2
- FSOXZQBMPBQKGJ-QSFUFRPTSA-N His-Ile-Ala Chemical compound [O-]C(=O)[C@H](C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]([NH3+])CC1=CN=CN1 FSOXZQBMPBQKGJ-QSFUFRPTSA-N 0.000 description 2
- MFQVZYSPCIZFMR-MGHWNKPDSA-N His-Ile-Phe Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CC2=CN=CN2)N MFQVZYSPCIZFMR-MGHWNKPDSA-N 0.000 description 2
- VYUXYMRNGALHEA-DLOVCJGASA-N His-Leu-Ala Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O VYUXYMRNGALHEA-DLOVCJGASA-N 0.000 description 2
- CHIAUHSHDARFBD-ULQDDVLXSA-N His-Pro-Tyr Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CN=CN1 CHIAUHSHDARFBD-ULQDDVLXSA-N 0.000 description 2
- VIJMRAIWYWRXSR-CIUDSAMLSA-N His-Ser-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CN=CN1 VIJMRAIWYWRXSR-CIUDSAMLSA-N 0.000 description 2
- JXUGDUWBMKIJDC-NAKRPEOUSA-N Ile-Ala-Arg Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O JXUGDUWBMKIJDC-NAKRPEOUSA-N 0.000 description 2
- QICVAHODWHIWIS-HTFCKZLJSA-N Ile-Ala-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)N QICVAHODWHIWIS-HTFCKZLJSA-N 0.000 description 2
- WECYRWOMWSCWNX-XUXIUFHCSA-N Ile-Arg-Leu Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(O)=O WECYRWOMWSCWNX-XUXIUFHCSA-N 0.000 description 2
- VZIFYHYNQDIPLI-HJWJTTGWSA-N Ile-Arg-Phe Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N VZIFYHYNQDIPLI-HJWJTTGWSA-N 0.000 description 2
- BGZIJZJBXRVBGJ-SXTJYALSSA-N Ile-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)N BGZIJZJBXRVBGJ-SXTJYALSSA-N 0.000 description 2
- QSPLUJGYOPZINY-ZPFDUUQYSA-N Ile-Asp-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N QSPLUJGYOPZINY-ZPFDUUQYSA-N 0.000 description 2
- PHIXPNQDGGILMP-YVNDNENWSA-N Ile-Glu-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N PHIXPNQDGGILMP-YVNDNENWSA-N 0.000 description 2
- UBHUJPVCJHPSEU-GRLWGSQLSA-N Ile-Glu-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)N UBHUJPVCJHPSEU-GRLWGSQLSA-N 0.000 description 2
- RWYCOSAAAJBJQL-KCTSRDHCSA-N Ile-Gly-Trp Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)N RWYCOSAAAJBJQL-KCTSRDHCSA-N 0.000 description 2
- OWSWUWDMSNXTNE-GMOBBJLQSA-N Ile-Pro-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)O)N OWSWUWDMSNXTNE-GMOBBJLQSA-N 0.000 description 2
- XOZOSAUOGRPCES-STECZYCISA-N Ile-Pro-Tyr Chemical compound CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 XOZOSAUOGRPCES-STECZYCISA-N 0.000 description 2
- YCKPUHHMCFSUMD-IUKAMOBKSA-N Ile-Thr-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N YCKPUHHMCFSUMD-IUKAMOBKSA-N 0.000 description 2
- GMUYXHHJAGQHGB-TUBUOCAGSA-N Ile-Thr-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N GMUYXHHJAGQHGB-TUBUOCAGSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- HGCNKOLVKRAVHD-UHFFFAOYSA-N L-Met-L-Phe Natural products CSCCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 HGCNKOLVKRAVHD-UHFFFAOYSA-N 0.000 description 2
- SITWEMZOJNKJCH-UHFFFAOYSA-N L-alanine-L-arginine Natural products CC(N)C(=O)NC(C(O)=O)CCCNC(N)=N SITWEMZOJNKJCH-UHFFFAOYSA-N 0.000 description 2
- SENJXOPIZNYLHU-UHFFFAOYSA-N L-leucyl-L-arginine Natural products CC(C)CC(N)C(=O)NC(C(O)=O)CCCN=C(N)N SENJXOPIZNYLHU-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 241000880493 Leptailurus serval Species 0.000 description 2
- LJHGALIOHLRRQN-DCAQKATOSA-N Leu-Ala-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N LJHGALIOHLRRQN-DCAQKATOSA-N 0.000 description 2
- BQSLGJHIAGOZCD-CIUDSAMLSA-N Leu-Ala-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O BQSLGJHIAGOZCD-CIUDSAMLSA-N 0.000 description 2
- HBJZFCIVFIBNSV-DCAQKATOSA-N Leu-Arg-Asn Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(N)=O)C(O)=O HBJZFCIVFIBNSV-DCAQKATOSA-N 0.000 description 2
- KSZCCRIGNVSHFH-UWVGGRQHSA-N Leu-Arg-Gly Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O KSZCCRIGNVSHFH-UWVGGRQHSA-N 0.000 description 2
- VCSBGUACOYUIGD-CIUDSAMLSA-N Leu-Asn-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O VCSBGUACOYUIGD-CIUDSAMLSA-N 0.000 description 2
- MMEDVBWCMGRKKC-GARJFASQSA-N Leu-Asp-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N MMEDVBWCMGRKKC-GARJFASQSA-N 0.000 description 2
- CLVUXCBGKUECIT-HJGDQZAQSA-N Leu-Asp-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O CLVUXCBGKUECIT-HJGDQZAQSA-N 0.000 description 2
- PPBKJAQJAUHZKX-SRVKXCTJSA-N Leu-Cys-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@H](C(O)=O)CC(C)C PPBKJAQJAUHZKX-SRVKXCTJSA-N 0.000 description 2
- VPKIQULSKFVCSM-SRVKXCTJSA-N Leu-Gln-Arg Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O VPKIQULSKFVCSM-SRVKXCTJSA-N 0.000 description 2
- DZQMXBALGUHGJT-GUBZILKMSA-N Leu-Glu-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O DZQMXBALGUHGJT-GUBZILKMSA-N 0.000 description 2
- POZULHZYLPGXMR-ONGXEEELSA-N Leu-Gly-Val Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O POZULHZYLPGXMR-ONGXEEELSA-N 0.000 description 2
- VZBIUJURDLFFOE-IHRRRGAJSA-N Leu-His-Arg Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O VZBIUJURDLFFOE-IHRRRGAJSA-N 0.000 description 2
- AOFYPTOHESIBFZ-KKUMJFAQSA-N Leu-His-His Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1cnc[nH]1)C(O)=O AOFYPTOHESIBFZ-KKUMJFAQSA-N 0.000 description 2
- DBSLVQBXKVKDKJ-BJDJZHNGSA-N Leu-Ile-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O DBSLVQBXKVKDKJ-BJDJZHNGSA-N 0.000 description 2
- QJXHMYMRGDOHRU-NHCYSSNCSA-N Leu-Ile-Gly Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O QJXHMYMRGDOHRU-NHCYSSNCSA-N 0.000 description 2
- DSFYPIUSAMSERP-IHRRRGAJSA-N Leu-Leu-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N DSFYPIUSAMSERP-IHRRRGAJSA-N 0.000 description 2
- YOKVEHGYYQEQOP-QWRGUYRKSA-N Leu-Leu-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O YOKVEHGYYQEQOP-QWRGUYRKSA-N 0.000 description 2
- KYIIALJHAOIAHF-KKUMJFAQSA-N Leu-Leu-His Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 KYIIALJHAOIAHF-KKUMJFAQSA-N 0.000 description 2
- IEWBEPKLKUXQBU-VOAKCMCISA-N Leu-Leu-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O IEWBEPKLKUXQBU-VOAKCMCISA-N 0.000 description 2
- ZAVCJRJOQKIOJW-KKUMJFAQSA-N Leu-Phe-Asp Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(O)=O)C(O)=O)CC1=CC=CC=C1 ZAVCJRJOQKIOJW-KKUMJFAQSA-N 0.000 description 2
- YWKNKRAKOCLOLH-OEAJRASXSA-N Leu-Phe-Thr Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)O)C(O)=O)CC1=CC=CC=C1 YWKNKRAKOCLOLH-OEAJRASXSA-N 0.000 description 2
- XOWMDXHFSBCAKQ-SRVKXCTJSA-N Leu-Ser-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC(C)C XOWMDXHFSBCAKQ-SRVKXCTJSA-N 0.000 description 2
- SBANPBVRHYIMRR-UHFFFAOYSA-N Leu-Ser-Pro Natural products CC(C)CC(N)C(=O)NC(CO)C(=O)N1CCCC1C(O)=O SBANPBVRHYIMRR-UHFFFAOYSA-N 0.000 description 2
- LFSQWRSVPNKJGP-WDCWCFNPSA-N Leu-Thr-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CCC(O)=O LFSQWRSVPNKJGP-WDCWCFNPSA-N 0.000 description 2
- QWWPYKKLXWOITQ-VOAKCMCISA-N Leu-Thr-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC(C)C QWWPYKKLXWOITQ-VOAKCMCISA-N 0.000 description 2
- CNWDWAMPKVYJJB-NUTKFTJISA-N Leu-Trp-Ala Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(O)=O)=CNC2=C1 CNWDWAMPKVYJJB-NUTKFTJISA-N 0.000 description 2
- FBNPMTNBFFAMMH-AVGNSLFASA-N Leu-Val-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N FBNPMTNBFFAMMH-AVGNSLFASA-N 0.000 description 2
- FBNPMTNBFFAMMH-UHFFFAOYSA-N Leu-Val-Arg Natural products CC(C)CC(N)C(=O)NC(C(C)C)C(=O)NC(C(O)=O)CCCN=C(N)N FBNPMTNBFFAMMH-UHFFFAOYSA-N 0.000 description 2
- NTEVEUCLFMWSND-SRVKXCTJSA-N Lys-Arg-Gln Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(O)=O NTEVEUCLFMWSND-SRVKXCTJSA-N 0.000 description 2
- YXTKSLRSRXKXNV-IHRRRGAJSA-N Lys-His-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CCCCN)N YXTKSLRSRXKXNV-IHRRRGAJSA-N 0.000 description 2
- 102000013460 Malate Dehydrogenase Human genes 0.000 description 2
- 108010026217 Malate Dehydrogenase Proteins 0.000 description 2
- MUYQDMBLDFEVRJ-LSJOCFKGSA-N Met-Ala-His Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CNC=N1 MUYQDMBLDFEVRJ-LSJOCFKGSA-N 0.000 description 2
- CWFYZYQMUDWGTI-GUBZILKMSA-N Met-Arg-Asp Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O CWFYZYQMUDWGTI-GUBZILKMSA-N 0.000 description 2
- UYAKZHGIPRCGPF-CIUDSAMLSA-N Met-Glu-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)N UYAKZHGIPRCGPF-CIUDSAMLSA-N 0.000 description 2
- WXJXYMFUTRXRGO-UWVGGRQHSA-N Met-His-Gly Chemical compound CSCC[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CNC=N1 WXJXYMFUTRXRGO-UWVGGRQHSA-N 0.000 description 2
- RXWPLVRJQNWXRQ-IHRRRGAJSA-N Met-His-His Chemical compound C([C@H](NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC=1N=CNC=1)C(O)=O)C1=CNC=N1 RXWPLVRJQNWXRQ-IHRRRGAJSA-N 0.000 description 2
- ILKCLLLOGPDNIP-RCWTZXSCSA-N Met-Met-Thr Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O ILKCLLLOGPDNIP-RCWTZXSCSA-N 0.000 description 2
- ZDJICAUBMUKVEJ-CIUDSAMLSA-N Met-Ser-Gln Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(N)=O ZDJICAUBMUKVEJ-CIUDSAMLSA-N 0.000 description 2
- QQPMHUCGDRJFQK-RHYQMDGZSA-N Met-Thr-Leu Chemical compound CSCC[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC(C)C QQPMHUCGDRJFQK-RHYQMDGZSA-N 0.000 description 2
- WUGMRIBZSVSJNP-UHFFFAOYSA-N N-L-alanyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)C)C(O)=O)=CNC2=C1 WUGMRIBZSVSJNP-UHFFFAOYSA-N 0.000 description 2
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 2
- 101100068676 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) gln-1 gene Proteins 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 102000003992 Peroxidases Human genes 0.000 description 2
- BJEYSVHMGIJORT-NHCYSSNCSA-N Phe-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=CC=C1 BJEYSVHMGIJORT-NHCYSSNCSA-N 0.000 description 2
- CYZBFPYMSJGBRL-DRZSPHRISA-N Phe-Ala-Glu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O CYZBFPYMSJGBRL-DRZSPHRISA-N 0.000 description 2
- QMMRHASQEVCJGR-UBHSHLNASA-N Phe-Ala-Pro Chemical compound C([C@H](N)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(O)=O)C1=CC=CC=C1 QMMRHASQEVCJGR-UBHSHLNASA-N 0.000 description 2
- DPUOLKQSMYLRDR-UBHSHLNASA-N Phe-Arg-Ala Chemical compound NC(N)=NCCC[C@@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 DPUOLKQSMYLRDR-UBHSHLNASA-N 0.000 description 2
- RIYZXJVARWJLKS-KKUMJFAQSA-N Phe-Asp-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 RIYZXJVARWJLKS-KKUMJFAQSA-N 0.000 description 2
- BFYHIHGIHGROAT-HTUGSXCWSA-N Phe-Glu-Thr Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O BFYHIHGIHGROAT-HTUGSXCWSA-N 0.000 description 2
- NHCKESBLOMHIIE-IRXDYDNUSA-N Phe-Gly-Phe Chemical compound C([C@H](N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 NHCKESBLOMHIIE-IRXDYDNUSA-N 0.000 description 2
- QPVFUAUFEBPIPT-CDMKHQONSA-N Phe-Gly-Thr Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O QPVFUAUFEBPIPT-CDMKHQONSA-N 0.000 description 2
- RSPUIENXSJYZQO-JYJNAYRXSA-N Phe-Leu-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=CC=C1 RSPUIENXSJYZQO-JYJNAYRXSA-N 0.000 description 2
- GPLWGAYGROGDEN-BZSNNMDCSA-N Phe-Phe-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(O)=O GPLWGAYGROGDEN-BZSNNMDCSA-N 0.000 description 2
- CQZNGNCAIXMAIQ-UBHSHLNASA-N Pro-Ala-Phe Chemical compound C[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](Cc1ccccc1)C(O)=O CQZNGNCAIXMAIQ-UBHSHLNASA-N 0.000 description 2
- ICTZKEXYDDZZFP-SRVKXCTJSA-N Pro-Arg-Pro Chemical compound N([C@@H](CCCN=C(N)N)C(=O)N1[C@@H](CCC1)C(O)=O)C(=O)[C@@H]1CCCN1 ICTZKEXYDDZZFP-SRVKXCTJSA-N 0.000 description 2
- GDXZRWYXJSGWIV-GMOBBJLQSA-N Pro-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1 GDXZRWYXJSGWIV-GMOBBJLQSA-N 0.000 description 2
- HXOLCSYHGRNXJJ-IHRRRGAJSA-N Pro-Asp-Phe Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O HXOLCSYHGRNXJJ-IHRRRGAJSA-N 0.000 description 2
- YFNOUBWUIIJQHF-LPEHRKFASA-N Pro-Asp-Pro Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CC(=O)O)C(=O)N2CCC[C@@H]2C(=O)O YFNOUBWUIIJQHF-LPEHRKFASA-N 0.000 description 2
- SFECXGVELZFBFJ-VEVYYDQMSA-N Pro-Asp-Thr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SFECXGVELZFBFJ-VEVYYDQMSA-N 0.000 description 2
- PEYNRYREGPAOAK-LSJOCFKGSA-N Pro-His-Ala Chemical compound C([C@@H](C(=O)N[C@@H](C)C([O-])=O)NC(=O)[C@H]1[NH2+]CCC1)C1=CN=CN1 PEYNRYREGPAOAK-LSJOCFKGSA-N 0.000 description 2
- GSPPWVHVBBSPSY-FHWLQOOXSA-N Pro-His-Trp Chemical compound OC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCCN1 GSPPWVHVBBSPSY-FHWLQOOXSA-N 0.000 description 2
- SVXXJYJCRNKDDE-AVGNSLFASA-N Pro-Pro-His Chemical compound C([C@@H](C(=O)O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H]1NCCC1)C1=CN=CN1 SVXXJYJCRNKDDE-AVGNSLFASA-N 0.000 description 2
- LNICFEXCAHIJOR-DCAQKATOSA-N Pro-Ser-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O LNICFEXCAHIJOR-DCAQKATOSA-N 0.000 description 2
- SHTKRJHDMNSKRM-ULQDDVLXSA-N Pro-Tyr-His Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CC3=CN=CN3)C(=O)O SHTKRJHDMNSKRM-ULQDDVLXSA-N 0.000 description 2
- PGSWNLRYYONGPE-JYJNAYRXSA-N Pro-Val-Tyr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O PGSWNLRYYONGPE-JYJNAYRXSA-N 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 108010053763 Pyruvate Carboxylase Proteins 0.000 description 2
- 102100039895 Pyruvate carboxylase, mitochondrial Human genes 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
- LVVBAKCGXXUHFO-ZLUOBGJFSA-N Ser-Ala-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(O)=O LVVBAKCGXXUHFO-ZLUOBGJFSA-N 0.000 description 2
- BRKHVZNDAOMAHX-BIIVOSGPSA-N Ser-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CO)N BRKHVZNDAOMAHX-BIIVOSGPSA-N 0.000 description 2
- QGMLKFGTGXWAHF-IHRRRGAJSA-N Ser-Arg-Phe Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O QGMLKFGTGXWAHF-IHRRRGAJSA-N 0.000 description 2
- MMAPOBOTRUVNKJ-ZLUOBGJFSA-N Ser-Asp-Ser Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CO)N)C(=O)O MMAPOBOTRUVNKJ-ZLUOBGJFSA-N 0.000 description 2
- OJPHFSOMBZKQKQ-GUBZILKMSA-N Ser-Gln-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CO OJPHFSOMBZKQKQ-GUBZILKMSA-N 0.000 description 2
- BKZYBLLIBOBOOW-GHCJXIJMSA-N Ser-Ile-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(O)=O BKZYBLLIBOBOOW-GHCJXIJMSA-N 0.000 description 2
- IFPBAGJBHSNYPR-ZKWXMUAHSA-N Ser-Ile-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O IFPBAGJBHSNYPR-ZKWXMUAHSA-N 0.000 description 2
- FUMGHWDRRFCKEP-CIUDSAMLSA-N Ser-Leu-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O FUMGHWDRRFCKEP-CIUDSAMLSA-N 0.000 description 2
- VMLONWHIORGALA-SRVKXCTJSA-N Ser-Leu-Leu Chemical compound CC(C)C[C@@H](C([O-])=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]([NH3+])CO VMLONWHIORGALA-SRVKXCTJSA-N 0.000 description 2
- NUEHQDHDLDXCRU-GUBZILKMSA-N Ser-Pro-Arg Chemical compound OC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(O)=O NUEHQDHDLDXCRU-GUBZILKMSA-N 0.000 description 2
- FKYWFUYPVKLJLP-DCAQKATOSA-N Ser-Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CO FKYWFUYPVKLJLP-DCAQKATOSA-N 0.000 description 2
- XJDMUQCLVSCRSJ-VZFHVOOUSA-N Ser-Thr-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O XJDMUQCLVSCRSJ-VZFHVOOUSA-N 0.000 description 2
- RXUOAOOZIWABBW-XGEHTFHBSA-N Ser-Thr-Arg Chemical compound OC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N RXUOAOOZIWABBW-XGEHTFHBSA-N 0.000 description 2
- ANOQEBQWIAYIMV-AEJSXWLSSA-N Ser-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CO)N ANOQEBQWIAYIMV-AEJSXWLSSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- IGROJMCBGRFRGI-YTLHQDLWSA-N Thr-Ala-Ala Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(O)=O IGROJMCBGRFRGI-YTLHQDLWSA-N 0.000 description 2
- GLQFKOVWXPPFTP-VEVYYDQMSA-N Thr-Arg-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O GLQFKOVWXPPFTP-VEVYYDQMSA-N 0.000 description 2
- MQBTXMPQNCGSSZ-OSUNSFLBSA-N Thr-Arg-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)CCCN=C(N)N MQBTXMPQNCGSSZ-OSUNSFLBSA-N 0.000 description 2
- NAXBBCLCEOTAIG-RHYQMDGZSA-N Thr-Arg-Lys Chemical compound NC(N)=NCCC[C@H](NC(=O)[C@@H](N)[C@H](O)C)C(=O)N[C@@H](CCCCN)C(O)=O NAXBBCLCEOTAIG-RHYQMDGZSA-N 0.000 description 2
- JNQZPAWOPBZGIX-RCWTZXSCSA-N Thr-Arg-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)CCCN=C(N)N JNQZPAWOPBZGIX-RCWTZXSCSA-N 0.000 description 2
- LMMDEZPNUTZJAY-GCJQMDKQSA-N Thr-Asp-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O LMMDEZPNUTZJAY-GCJQMDKQSA-N 0.000 description 2
- APIQKJYZDWVOCE-VEVYYDQMSA-N Thr-Asp-Met Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCSC)C(O)=O APIQKJYZDWVOCE-VEVYYDQMSA-N 0.000 description 2
- ZUUDNCOCILSYAM-KKHAAJSZSA-N Thr-Asp-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O ZUUDNCOCILSYAM-KKHAAJSZSA-N 0.000 description 2
- RKDFEMGVMMYYNG-WDCWCFNPSA-N Thr-Gln-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O RKDFEMGVMMYYNG-WDCWCFNPSA-N 0.000 description 2
- DIPIPFHFLPTCLK-LOKLDPHHSA-N Thr-Gln-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N1CCC[C@@H]1C(=O)O)N)O DIPIPFHFLPTCLK-LOKLDPHHSA-N 0.000 description 2
- FHDLKMFZKRUQCE-HJGDQZAQSA-N Thr-Glu-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O FHDLKMFZKRUQCE-HJGDQZAQSA-N 0.000 description 2
- XOTBWOCSLMBGMF-SUSMZKCASA-N Thr-Glu-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XOTBWOCSLMBGMF-SUSMZKCASA-N 0.000 description 2
- DJDSEDOKJTZBAR-ZDLURKLDSA-N Thr-Gly-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O DJDSEDOKJTZBAR-ZDLURKLDSA-N 0.000 description 2
- JKGGPMOUIAAJAA-YEPSODPASA-N Thr-Gly-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O JKGGPMOUIAAJAA-YEPSODPASA-N 0.000 description 2
- YUPVPKZBKCLFLT-QTKMDUPCSA-N Thr-His-Val Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](C(C)C)C(=O)O)N)O YUPVPKZBKCLFLT-QTKMDUPCSA-N 0.000 description 2
- RRRRCRYTLZVCEN-HJGDQZAQSA-N Thr-Leu-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O RRRRCRYTLZVCEN-HJGDQZAQSA-N 0.000 description 2
- HOVLHEKTGVIKAP-WDCWCFNPSA-N Thr-Leu-Gln Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O HOVLHEKTGVIKAP-WDCWCFNPSA-N 0.000 description 2
- WPSKTVVMQCXPRO-BWBBJGPYSA-N Thr-Ser-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O WPSKTVVMQCXPRO-BWBBJGPYSA-N 0.000 description 2
- GQPQJNMVELPZNQ-GBALPHGKSA-N Thr-Ser-Trp Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)N)O GQPQJNMVELPZNQ-GBALPHGKSA-N 0.000 description 2
- ZESGVALRVJIVLZ-VFCFLDTKSA-N Thr-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@@H]1C(=O)O)N)O ZESGVALRVJIVLZ-VFCFLDTKSA-N 0.000 description 2
- MNYNCKZAEIAONY-XGEHTFHBSA-N Thr-Val-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O MNYNCKZAEIAONY-XGEHTFHBSA-N 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- GTNCSPKYWCJZAC-XIRDDKMYSA-N Trp-Asp-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N GTNCSPKYWCJZAC-XIRDDKMYSA-N 0.000 description 2
- NKUIXQOJUAEIET-AQZXSJQPSA-N Trp-Asp-Thr Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@H](O)C)C(O)=O)=CNC2=C1 NKUIXQOJUAEIET-AQZXSJQPSA-N 0.000 description 2
- RQLNEFOBQAVGSY-WDSOQIARSA-N Trp-Met-Leu Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(O)=O RQLNEFOBQAVGSY-WDSOQIARSA-N 0.000 description 2
- BIBZRFIKOLGWFQ-XIRDDKMYSA-N Trp-Pro-Gln Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CC2=CNC3=CC=CC=C32)N)C(=O)N[C@@H](CCC(=O)N)C(=O)O BIBZRFIKOLGWFQ-XIRDDKMYSA-N 0.000 description 2
- MBLJBGZWLHTJBH-SZMVWBNQSA-N Trp-Val-Arg Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)=CNC2=C1 MBLJBGZWLHTJBH-SZMVWBNQSA-N 0.000 description 2
- QHLIUFUEUDFAOT-MGHWNKPDSA-N Tyr-Leu-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(C=C1)O)N QHLIUFUEUDFAOT-MGHWNKPDSA-N 0.000 description 2
- NSGZILIDHCIZAM-KKUMJFAQSA-N Tyr-Leu-Ser Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N NSGZILIDHCIZAM-KKUMJFAQSA-N 0.000 description 2
- BBSPTGPYIPGTKH-JYJNAYRXSA-N Tyr-Met-Arg Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N BBSPTGPYIPGTKH-JYJNAYRXSA-N 0.000 description 2
- FZSPNKUFROZBSG-ZKWXMUAHSA-N Val-Ala-Asp Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(O)=O FZSPNKUFROZBSG-ZKWXMUAHSA-N 0.000 description 2
- JIODCDXKCJRMEH-NHCYSSNCSA-N Val-Arg-Gln Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N JIODCDXKCJRMEH-NHCYSSNCSA-N 0.000 description 2
- XPYNXORPPVTVQK-SRVKXCTJSA-N Val-Arg-Met Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCSC)C(=O)O)N XPYNXORPPVTVQK-SRVKXCTJSA-N 0.000 description 2
- UDLYXGYWTVOIKU-QXEWZRGKSA-N Val-Asn-Arg Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N UDLYXGYWTVOIKU-QXEWZRGKSA-N 0.000 description 2
- BWVHQINTNLVWGZ-ZKWXMUAHSA-N Val-Cys-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)O)C(=O)O)N BWVHQINTNLVWGZ-ZKWXMUAHSA-N 0.000 description 2
- XGJLNBNZNMVJRS-NRPADANISA-N Val-Glu-Ala Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O XGJLNBNZNMVJRS-NRPADANISA-N 0.000 description 2
- VLDMQVZZWDOKQF-AUTRQRHGSA-N Val-Glu-Gln Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N VLDMQVZZWDOKQF-AUTRQRHGSA-N 0.000 description 2
- CELJCNRXKZPTCX-XPUUQOCRSA-N Val-Gly-Ala Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@@H](C)C(O)=O CELJCNRXKZPTCX-XPUUQOCRSA-N 0.000 description 2
- BEGDZYNDCNEGJZ-XVKPBYJWSA-N Val-Gly-Gln Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCC(N)=O BEGDZYNDCNEGJZ-XVKPBYJWSA-N 0.000 description 2
- BVWPHWLFGRCECJ-JSGCOSHPSA-N Val-Gly-Tyr Chemical compound CC(C)[C@@H](C(=O)NCC(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N BVWPHWLFGRCECJ-JSGCOSHPSA-N 0.000 description 2
- CPGJELLYDQEDRK-NAKRPEOUSA-N Val-Ile-Ala Chemical compound CC[C@H](C)[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](C)C(O)=O CPGJELLYDQEDRK-NAKRPEOUSA-N 0.000 description 2
- AEMPCGRFEZTWIF-IHRRRGAJSA-N Val-Leu-Lys Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(O)=O AEMPCGRFEZTWIF-IHRRRGAJSA-N 0.000 description 2
- SYSWVVCYSXBVJG-RHYQMDGZSA-N Val-Leu-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)N)O SYSWVVCYSXBVJG-RHYQMDGZSA-N 0.000 description 2
- YKNOJPJWNVHORX-UNQGMJICSA-N Val-Phe-Thr Chemical compound CC(C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)O)C(O)=O)CC1=CC=CC=C1 YKNOJPJWNVHORX-UNQGMJICSA-N 0.000 description 2
- VTIAEOKFUJJBTC-YDHLFZDLSA-N Val-Tyr-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N VTIAEOKFUJJBTC-YDHLFZDLSA-N 0.000 description 2
- 238000005273 aeration Methods 0.000 description 2
- 108010047495 alanylglycine Proteins 0.000 description 2
- 108010087924 alanylproline Proteins 0.000 description 2
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 108010069926 arginyl-glycyl-serine Proteins 0.000 description 2
- 108010043240 arginyl-leucyl-glycine Proteins 0.000 description 2
- 108010018691 arginyl-threonyl-arginine Proteins 0.000 description 2
- 108010068380 arginylarginine Proteins 0.000 description 2
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 2
- 108010069205 aspartyl-phenylalanine Proteins 0.000 description 2
- 108010047857 aspartylglycine Proteins 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 238000011098 chromatofocusing Methods 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 210000004748 cultured cell Anatomy 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 238000011033 desalting Methods 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 108010013768 glutamyl-aspartyl-proline Proteins 0.000 description 2
- 108010055341 glutamyl-glutamic acid Proteins 0.000 description 2
- 108010049041 glutamylalanine Proteins 0.000 description 2
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 2
- JYPCXBJRLBHWME-UHFFFAOYSA-N glycyl-L-prolyl-L-arginine Natural products NCC(=O)N1CCCC1C(=O)NC(CCCN=C(N)N)C(O)=O JYPCXBJRLBHWME-UHFFFAOYSA-N 0.000 description 2
- 108010075431 glycyl-alanyl-phenylalanine Proteins 0.000 description 2
- 108010072405 glycyl-aspartyl-glycine Proteins 0.000 description 2
- 108010078326 glycyl-glycyl-valine Proteins 0.000 description 2
- 108010082286 glycyl-seryl-alanine Proteins 0.000 description 2
- 108010048994 glycyl-tyrosyl-alanine Proteins 0.000 description 2
- 108010050848 glycylleucine Proteins 0.000 description 2
- 108010037850 glycylvaline Proteins 0.000 description 2
- 108010050343 histidyl-alanyl-glutamine Proteins 0.000 description 2
- 108010045383 histidyl-glycyl-glutamic acid Proteins 0.000 description 2
- 108010036413 histidylglycine Proteins 0.000 description 2
- 108010085325 histidylproline Proteins 0.000 description 2
- 108010018006 histidylserine Proteins 0.000 description 2
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 2
- 238000009533 lab test Methods 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 108010076756 leucyl-alanyl-phenylalanine Proteins 0.000 description 2
- 108010000761 leucylarginine Proteins 0.000 description 2
- 108010091871 leucylmethionine Proteins 0.000 description 2
- 239000006166 lysate Substances 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 2
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 2
- 229910017464 nitrogen compound Inorganic materials 0.000 description 2
- 150000002830 nitrogen compounds Chemical class 0.000 description 2
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 description 2
- 108010024607 phenylalanylalanine Proteins 0.000 description 2
- 108010012581 phenylalanylglutamate Proteins 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- SOSDSEAIODNVPX-UHFFFAOYSA-M potassium;1-carboxyethenyl hydrogen phosphate Chemical compound [K+].OC(=O)C(=C)OP(O)([O-])=O SOSDSEAIODNVPX-UHFFFAOYSA-M 0.000 description 2
- 102220201851 rs143406017 Human genes 0.000 description 2
- 238000011218 seed culture Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- 108010061238 threonyl-glycine Proteins 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 108010080629 tryptophan-leucine Proteins 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- UAIUNKRWKOVEES-UHFFFAOYSA-N 3,3',5,5'-tetramethylbenzidine Chemical compound CC1=C(N)C(C)=CC(C=2C=C(C)C(N)=C(C)C=2)=C1 UAIUNKRWKOVEES-UHFFFAOYSA-N 0.000 description 1
- BYXHQQCXAJARLQ-ZLUOBGJFSA-N Ala-Ala-Ala Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(O)=O BYXHQQCXAJARLQ-ZLUOBGJFSA-N 0.000 description 1
- 101710130006 Beta-glucanase Proteins 0.000 description 1
- PLBJMUUEGBBHRH-ZLUOBGJFSA-N Cys-Ala-Asn Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(O)=O PLBJMUUEGBBHRH-ZLUOBGJFSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- NBSCHQHZLSJFNQ-GASJEMHNSA-N D-Glucose 6-phosphate Chemical compound OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O NBSCHQHZLSJFNQ-GASJEMHNSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 238000007399 DNA isolation Methods 0.000 description 1
- 241001302584 Escherichia coli str. K-12 substr. W3110 Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- VFRROHXSMXFLSN-UHFFFAOYSA-N Glc6P Natural products OP(=O)(O)OCC(O)C(O)C(O)C(O)C=O VFRROHXSMXFLSN-UHFFFAOYSA-N 0.000 description 1
- CAXXTYYGFYTBPV-IUCAKERBSA-N Gln-Leu-Gly Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O CAXXTYYGFYTBPV-IUCAKERBSA-N 0.000 description 1
- XHUCVVHRLNPZSZ-CIUDSAMLSA-N Glu-Gln-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O XHUCVVHRLNPZSZ-CIUDSAMLSA-N 0.000 description 1
- UMIRPYLZFKOEOH-YVNDNENWSA-N Glu-Gln-Ile Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O UMIRPYLZFKOEOH-YVNDNENWSA-N 0.000 description 1
- MTONDYJJCIBZTK-PEDHHIEDSA-N Ile-Ile-Met Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)O)N MTONDYJJCIBZTK-PEDHHIEDSA-N 0.000 description 1
- YGDWPQCLFJNMOL-MNXVOIDGSA-N Ile-Leu-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N YGDWPQCLFJNMOL-MNXVOIDGSA-N 0.000 description 1
- JRJLGNFWYFSJHB-HOCLYGCPSA-N Leu-Gly-Trp Chemical compound [H]N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O JRJLGNFWYFSJHB-HOCLYGCPSA-N 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- AJHCSUXXECOXOY-UHFFFAOYSA-N N-glycyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)CN)C(O)=O)=CNC2=C1 AJHCSUXXECOXOY-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 101710100247 Phosphoenolpyruvate carboxylase 3 Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- ZMLRZBWCXPQADC-TUAOUCFPSA-N Pro-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@@H]2CCCN2 ZMLRZBWCXPQADC-TUAOUCFPSA-N 0.000 description 1
- 101001009851 Rattus norvegicus Guanylate cyclase 2G Proteins 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- JISIQDCOHJOOPU-WFBYXXMGSA-N Trp-Cys-Ala Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(O)=O JISIQDCOHJOOPU-WFBYXXMGSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- 229940100228 acetyl coenzyme a Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- RNBGYGVWRKECFJ-ZXXMMSQZSA-N alpha-D-fructofuranose 1,6-bisphosphate Chemical compound O[C@H]1[C@H](O)[C@](O)(COP(O)(O)=O)O[C@@H]1COP(O)(O)=O RNBGYGVWRKECFJ-ZXXMMSQZSA-N 0.000 description 1
- 108010050025 alpha-glutamyltryptophan Proteins 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000003169 complementation method Methods 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000000432 density-gradient centrifugation Methods 0.000 description 1
- 230000003544 deproteinization Effects 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 229940025237 fructose 1,6-diphosphate Drugs 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229940045189 glucose-6-phosphate Drugs 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 229910001410 inorganic ion Inorganic materials 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 150000002897 organic nitrogen compounds Chemical class 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 239000006152 selective media Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L sodium sulphate Substances [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は試料中の炭酸ガス濃度を
測定するのに好適である、新規なホスホエノールピルビ
ン酸カルボキシラーゼをコードする遺伝子及びその用途
に関するものである。TECHNICAL FIELD The present invention relates to a gene encoding a novel phosphoenolpyruvate carboxylase, which is suitable for measuring the carbon dioxide concentration in a sample, and its use.
【0002】[0002]
【従来の技術】ホスホエノールピルビン酸カルボキシラ
ーゼは、ホスホエノールピルビン酸及び重炭酸イオンに
作用して、オキザロ酢酸とリン酸イオンを生成する反応
を触媒する酵素であり、臨床検査薬の分野では体液、特
に血清及び血漿中の重炭酸イオン測定用試薬に従来から
用いられてきた。このホスホエノールピルビン酸カルボ
キシラーゼの給源としては、多くの植物、原生動物、大
部分の細菌に存在することが報告されている(「蛋白
質、核酸、酵素」Vol.22, No.14(1977))。しかしこれら
のホスホエノールピルビン酸カルボキシラーゼの大部分
は活性発現のためのアクチベーターとして高価なアセチ
ルコエンザイムA、フルクトース−1,6−ジリン酸や
グルコース−6リン酸を必要としており、臨床検査薬用
酵素としては問題があった。またアクチベーターを必要
としないホスホエノールピルビン酸カルボキシラーゼは
一部の細菌及びC4植物に見いだされているが、臨床検
査薬用酵素としては安定性に問題があった。BACKGROUND OF THE INVENTION Phosphoenolpyruvate carboxylase is an enzyme that acts on phosphoenolpyruvate and bicarbonate ions to catalyze the reaction that produces oxaloacetate and phosphate ions. In particular, it has been conventionally used as a reagent for measuring bicarbonate ion in serum and plasma. As a source of this phosphoenolpyruvate carboxylase, it has been reported that it is present in many plants, protozoa, and most bacteria ("Protein, nucleic acid, enzyme" Vol.22, No.14 (1977)). . However, most of these phosphoenolpyruvate carboxylases require expensive acetyl-coenzyme A, fructose-1,6-diphosphate and glucose-6-phosphate as activators for activity expression, and they are used as enzymes for clinical laboratory tests. Had a problem. Phosphoenolpyruvate carboxylase, which does not require an activator, has been found in some bacteria and C4 plants, but it has a problem in stability as an enzyme for clinical laboratory tests.
【0003】上記の問題点を解決するため鋭意研究を重
ねた結果、酢酸菌の一種が高価なアクチベーターを必要
とせず、且つ安定なホスホエノールピルビン酸カルボキ
シラーゼを生産することが見い出された(特願平5-1132
48号) 。As a result of intensive studies to solve the above problems, it was found that a kind of acetic acid bacterium does not require an expensive activator and produces stable phosphoenolpyruvate carboxylase (special feature). 5-1132
No. 48).
【0004】[0004]
【発明が解決しようとする課題】上記酢酸菌よりホスホ
エノールピルビン酸カルボキシラーゼを製造する場合、
生産性が低い点、多くの精製工程を必要とする点などか
ら製造コストが高くなり臨床検査薬用酵素の給源として
は問題であった。本発明の目的は、上記の問題点を解決
するため遺伝子工学的手法によって新規ホスホエノール
ピルビン酸カルボキシラーゼを純粋な形で大量供給し得
る手段を提供することにある。When phosphoenolpyruvate carboxylase is produced from the above-mentioned acetic acid bacterium,
Since the productivity is low and many purification steps are required, the manufacturing cost is high, which is a problem as a source of enzyme for clinical laboratory drugs. An object of the present invention is to provide a means capable of supplying a large amount of a novel phosphoenolpyruvate carboxylase in pure form by a genetic engineering method in order to solve the above problems.
【0005】[0005]
【課題を解決するための手段】本発明者らは、上記目的
を達成するため、ホスホエノールピルビン酸カルボキシ
ラーゼ生産菌としてアセトバクター・ハンゼニイ(cetab
acter hansenii) IFO14820 を選び、該菌体より抽出し
た染色体DNAよりホスホエノールピルビン酸カルボキ
シラーゼ遺伝子の単離に成功し、そのDNAの全構造を
決定した。更に該ホスホエノールピルビン酸カルボキシ
ラーゼを遺伝子工学的手法によって形質転換体に高生産
させることに成功し、高純度なホスホエノールピルビン
酸カルボキシラーゼを安価に大量供給することを可能に
した。[Means for Solving the Problems] In order to achieve the above-mentioned object, the inventors of the present invention have identified acetobacter hansenii as a phosphoenolpyruvate carboxylase-producing bacterium.
acter hansenii) IFO14820 was selected, the phosphoenolpyruvate carboxylase gene was successfully isolated from the chromosomal DNA extracted from the cells, and the total structure of the DNA was determined. Furthermore, the phosphoenolpyruvate carboxylase was successfully produced in a transformant at a high level by a genetic engineering technique, and a large amount of highly pure phosphoenolpyruvate carboxylase could be supplied inexpensively.
【0006】すなわち本発明は配列表・配列番号1に記
載されたアミノ酸配列をコードするDNAを含有するこ
とを特徴とするホスホエノールピルビン酸カルボキシラ
ーゼをコードするDNA断片である。That is, the present invention is a DNA fragment encoding phosphoenolpyruvate carboxylase, which comprises a DNA encoding the amino acid sequence set forth in SEQ ID NO: 1 of the Sequence Listing.
【0007】また本発明は上記DNA断片を含有する組
換えベクターである。The present invention is also a recombinant vector containing the above DNA fragment.
【0008】さらに本発明は上記組換えベクターにより
形質転換された形質転換体である。Further, the present invention is a transformant transformed with the above recombinant vector.
【0009】本発明は上記形質転換体を培地で培養し、
ホスホエノールピルビン酸カルボキシラーゼを生成さ
せ、該ホスホエノールピルビン酸カルボキシラーゼを採
取することを特徴とするホスホエノールピルビン酸カル
ボキシラーゼの製造法である。The present invention comprises culturing the above transformant in a medium,
A method for producing phosphoenolpyruvate carboxylase, which comprises producing phosphoenolpyruvate carboxylase and collecting the phosphoenolpyruvate carboxylase.
【0010】本発明の遺伝子は、例えばアセトバクター
・ハンゼニイ(Acertobacter hansenii) IFO 14820 を起
源とする。この菌株を培養する培地としては、炭素源、
窒素源、無機イオン、更に必要に応じて硝酸塩、リン酸
塩などを含有する培地を使用する。炭素源としてはグル
コース、ラクトースのような糖類あるいはグリセロール
やソルビトールのような糖アルコールなどを用いること
が出来る。窒素源としてはポリペプトン、トリプトン、
肉エキス、酵母エキスなどが利用できる。該菌体を培養
するに当たり、特に誘導物質等は必要なく、好気条件に
て、該菌株の最も良好に生育する温度、pHにて培養
し、ホスホエノールピルビン酸カルボキシラーゼの生産
量が最大になる時点まで培養する。The gene of the present invention originates from, for example, Acertobacter hansenii IFO 14820. As a medium for culturing this strain, a carbon source,
A medium containing a nitrogen source, inorganic ions, and optionally nitrates, phosphates, etc. is used. As the carbon source, sugars such as glucose and lactose or sugar alcohols such as glycerol and sorbitol can be used. As the nitrogen source, polypeptone, tryptone,
Meat extract, yeast extract, etc. can be used. In culturing the bacterium, an inducer or the like is not particularly necessary, and the phosphoenolpyruvate carboxylase production is maximized by culturing at a temperature and a pH at which the strain grows best under aerobic conditions. Incubate until time point.
【0011】培養した菌体よりホスホエノールピルビン
酸カルボキシラーゼを精製するには、以下のような方法
が用いられる。培養液より遠心分離にて菌体を回収し、
次いで菌体を破砕することによりホスホエノールピルビ
ン酸カルボキシラーゼを抽出する。菌体破砕方法として
は、例えばリゾチームの様な細胞壁溶解酵素による処理
や、超音波破砕、ガラスビーズ破砕、フレンチプレス破
砕のような物理的処理を用いることが出来る。このよう
にして得られた粗酵素抽出液を例えばポリエチレンイミ
ン処理により除核酸処理を行った後、硫安沈澱によりホ
スホエノールピルビン酸カルボキシラーゼ画分を回収す
る。このようにして得られたホスホエノールピルビン酸
カルボキシラーゼ画分は、例えばG−25ゲル濾過など
により脱塩した後、DEAEセファロースCL−6B
(ファルマシアLKB)→ハイドロキシルアパタイト
(生化学工業)→セファデックスG−200ゲル濾過
(ファルマシアLKB)→MonoP HR5/5クロ
マトフォーカシング(ファルマシアLKB)などにより
高純度に精製される。The following method is used to purify phosphoenolpyruvate carboxylase from cultured cells. Collect the cells from the culture by centrifugation,
Then, the cells are crushed to extract phosphoenolpyruvate carboxylase. Examples of the method for disrupting the cells include treatment with a cell wall lysing enzyme such as lysozyme, and physical treatment such as ultrasonic disruption, glass bead disruption, French press disruption. The crude enzyme extract thus obtained is subjected to nucleic acid removal treatment by, for example, polyethyleneimine treatment, and then the phosphoenolpyruvate carboxylase fraction is recovered by ammonium sulfate precipitation. The phosphoenolpyruvate carboxylase fraction thus obtained is desalted by, for example, G-25 gel filtration, and then DEAE Sepharose CL-6B.
(Pharmacia LKB) → Hydroxyl apatite (Seikagaku Corporation) → Sephadex G-200 gel filtration (Pharmacia LKB) → MonoP HR5 / 5 chromatofocusing (Pharmacia LKB) etc.
【0012】本発明者らが精製したタンパク質は、SD
S−ポリアクリルアミドゲル電気泳動的に均一なバンド
を示した。この時のホスホエノールピルビン酸カルボキ
シラーゼの比活性は84単位(U)/mg蛋白であった。尚、
カラムクロマトグラフィーの組み合わせは上記ステップ
に限定する必要はないものの、電気泳動的に均一なバン
ドにするには数段階のカラムクロマトグラフィー操作が
必要である。The protein purified by the present inventors is SD
S-polyacrylamide gel showed electrophoretically uniform bands. The specific activity of phosphoenolpyruvate carboxylase at this time was 84 units (U) / mg protein. still,
Although the combination of column chromatography does not have to be limited to the above steps, several steps of column chromatography operation are required to obtain an electrophoretically uniform band.
【0013】上記ホスホエノールピルビン酸カルボキシ
ラーゼの理化学的性質は以下の通りである。 (1)作用:以下の反応を触媒する。The physicochemical properties of the above phosphoenolpyruvate carboxylase are as follows. (1) Action: It catalyzes the following reaction.
【0014】ホスホエノールピルビン酸 + HCO3
- → オキザロ酢酸 + HPO4 2- Phosphoenolpyruvate + HCO 3
- → Oxaloacetate + HPO 4 2-
【0015】(2)至適作用pH:7.5〜8.0 (3)pH安定性:pH5.0〜8.0(25℃、24
時間処理) pH7.5〜8.5(10mM MgSO4 を含むトリ
ス緩衝液中で25℃、24時間処理) (4)至適温度:60℃ (5)熱安定性:45℃以下(pH7.0,15分処
理) (6)分子量:390,000±10,000(ゲル濾
過法) 100,000±5,000(SDS−PAGE) (7)比活性:84単位/mg蛋白 (8)アセチルCoAで活性化されない。(2) Optimum action pH: 7.5-8.0 (3) pH stability: pH 5.0-8.0 (25 ° C, 24
Time treatment) pH 7.5 to 8.5 (25 ° C. for 24 hours in Tris buffer containing 10 mM MgSO 4 ) (4) Optimum temperature: 60 ° C. (5) Thermal stability: 45 ° C. or less (pH 7. (6) Molecular weight: 390,000 ± 10,000 (gel filtration method) 100,000 ± 5,000 (SDS-PAGE) (7) Specific activity: 84 units / mg protein (8) Acetyl Not activated by CoA.
【0016】本発明の新規ホスホエノールピルビン酸カ
ルボキシラーゼをコードする遺伝子は、アセトバクター
・ハンゼニイIFO 14820 菌体から抽出しても良く、また
化学的に合成することもできる。上記遺伝子配列として
は、例えば配列表番号1に記載されたアミノ酸配列をコ
ードするDNA配列または配列表番号2に記載された塩
基配列を有するDNAまたは配列表番号2に記載された
配列に対し突然変異により変化させられたDNAなどを
挙げることが出来る。The gene encoding the novel phosphoenolpyruvate carboxylase of the present invention may be extracted from the bacterium of Acetobacter hansenii IFO 14820 or it may be chemically synthesized. As the gene sequence, for example, a DNA sequence encoding the amino acid sequence described in SEQ ID NO: 1 or a DNA having the base sequence described in SEQ ID NO: 2 or a sequence described in SEQ ID NO: 2 is mutated. DNAs that have been changed by
【0017】本発明の遺伝子は、例えばアセトバクター
・ハンゼニイIFO 14820 の染色体DNAを分離・精製し
た後、超音波破砕、制限酵素などを用いてDNAを切断
したものと、リニヤーな発現ベクターとを両DNAの平
滑末端または接着末端部においてDNAリガーゼなどに
より結合閉環させて組換えベクターとする。こうして得
られた組換えベクターは複製可能な宿主微生物に移入し
た後、ベクターのマーカーとホスホエノールピルビン酸
カルボキシラーゼ蛋白の発現を指標としてスクリーニン
グして、組換えDNAベクターを保持する微生物を得
る。ホスホエノールピルビン酸カルボキシラーゼ蛋白質
発現のスクリーニング方法としては、該蛋白質の抗体を
用いた抗原抗体反応による方法、直接該蛋白質の活性を
測定する方法、該蛋白質の欠損変異株を用いた栄養要求
性の相補による方法などを用いることができる。該蛋白
質を発現した微生物を培養し、該培養菌体から該組換え
ベクターを分離・精製し、次いで該組換えベクターから
ホスホエノールピルビン酸カルボキシラーゼ遺伝子を採
取すれば良い。The gene of the present invention includes, for example, a product obtained by separating and purifying chromosomal DNA of Acetobacter hansenii IFO 14820, then sonicating, cleaving the DNA using a restriction enzyme, and a linear expression vector. The blunt end or sticky end of the DNA is ligated and closed with a DNA ligase to give a recombinant vector. The recombinant vector thus obtained is transferred to a replicable host microorganism and then screened using the marker of the vector and the expression of phosphoenolpyruvate carboxylase protein as an index to obtain a microorganism carrying the recombinant DNA vector. As a screening method for phosphoenolpyruvate carboxylase protein expression, a method by an antigen-antibody reaction using an antibody of the protein, a method of directly measuring the activity of the protein, and an auxotrophic complementation method using a deletion mutant of the protein Can be used. A microorganism expressing the protein may be cultured, the recombinant vector may be separated and purified from the cultured cells, and then the phosphoenolpyruvate carboxylase gene may be collected from the recombinant vector.
【0018】遺伝子供与体であるアセトバクター・ハン
ゼニイIFO 14820 に由来するDNAは具体的に以下のよ
うに採取される。すなわち供与微生物を例えば液体培地
で約1〜3日間撹拌培養して得られた培養物を遠心分離
にて集菌し、次いでこれを溶菌させることによりホスホ
エノールピルビン酸カルボキシラーゼ遺伝子の含有溶菌
物を調製することが出来る。溶菌の方法としては、例え
ばリゾチームやβ−グルカナーゼなどの溶菌酵素により
処理が施され、必要に応じてプロテアーゼや他の酵素や
ラウリル硫酸ナトリウム(SDS)などの界面活性剤が
併用され、更に凍結融解やフレンチプレス処理の様な物
理的破砕方法と組み合わせても良い。The DNA derived from the gene donor, Acetobacter hansenii IFO 14820, is specifically collected as follows. That is, for example, a culture obtained by stirring and culturing a donor microorganism in a liquid medium for about 1 to 3 days is collected by centrifugation, and then lysed to prepare a lysate containing a phosphoenolpyruvate carboxylase gene. You can do it. As a lysing method, for example, a treatment with a lysing enzyme such as lysozyme or β-glucanase is performed, and if necessary, a protease or other enzyme and a surfactant such as sodium lauryl sulfate (SDS) are used together, and further freeze-thawing It may be combined with a physical crushing method such as or French press treatment.
【0019】このようにして得られた溶菌物からDNA
を分離・精製するには常法に従って例えばフェノール処
理やプロテアーゼ処理による除蛋白処理や、リボヌクレ
アーゼ処理、アルコール沈澱処理などの方法を適宜組み
合わせることにより行うことが出来る。微生物から分離
・精製されたDNAを切断する方法は、例えば超音波処
理、制限酵素処理などにより行うことが出来るが、好ま
しくは特定ヌクレオチド配列に作用するII型制限酵素が
適している。DNA from the lysate thus obtained
In order to separate and purify the product, a method such as deproteinization treatment with phenol treatment or protease treatment, ribonuclease treatment, alcohol precipitation treatment and the like can be appropriately combined according to a conventional method. The DNA separated and purified from the microorganism can be cleaved by, for example, sonication or restriction enzyme treatment, but a type II restriction enzyme acting on a specific nucleotide sequence is preferable.
【0020】ベクターとしては、宿主微生物内で自立的
に増殖し得るファージまたはプラスミドから遺伝子組換
え用として構築された物が適している。ファージとして
は、例えばエシェリヒア・コリー(Escherichia coli)を
宿主微生物とする場合には、λgt・10,λgt・1
1などが使用できる。またプラスミドとしては、例えば
エシェリヒア・コリーを宿主微生物とした場合、pBR
322、pUC19、pBluescriptなどが使
用できる。このようなベクターを先に述べたホスホエノ
ールピルビン酸カルボキシラーゼ遺伝子供与体である微
生物DNAの切断に使用した制限酵素で切断してベクタ
ー断片を得ることができるが、必ずしも該微生物DNA
の切断に使用した制限酵素と同一の制限酵素を用いる必
要はない。微生物DNA断片とベクターDNA断片とを
結合させる方法は、公知のDNAリガーゼを用いる方法
で有れば良く、例えば微生物DNA断片の接着末端とベ
クター断片の接着末端とのアニーリングの後、適当なD
NAリガーゼの使用により微生物DNA断片とベクター
断片との組換えベクターを作成する。必要ならば、アニ
ーリングの後、宿主微生物に移入して生体内のDNAリ
ガーゼを利用し、組換えベクターを作成することもでき
る。Suitable vectors are those constructed for gene recombination from phages or plasmids capable of autonomous growth in host microorganisms. As the phage, for example, when Escherichia coli is used as a host microorganism, λgt · 10, λgt · 1
1 etc. can be used. As a plasmid, for example, when Escherichia coli is used as a host microorganism, pBR
322, pUC19, pBluescript, etc. can be used. Such a vector can be cleaved with the restriction enzyme used for cleaving the phosphoenolpyruvate carboxylase gene donor microbial DNA described above to obtain a vector fragment.
It is not necessary to use the same restriction enzyme as that used for the cleavage of The method for ligating the microbial DNA fragment and the vector DNA fragment may be a method using a known DNA ligase. For example, after annealing the cohesive ends of the microbial DNA fragment and the vector fragment, a suitable D
A recombinant vector of a microbial DNA fragment and a vector fragment is prepared by using NA ligase. If necessary, the recombinant vector can be prepared by using the in-vivo DNA ligase by transferring into a host microorganism after annealing.
【0021】宿主微生物としては、組換えベクターが安
定且つ自律的に増殖可能で、且つ外来性遺伝子の形質発
現できる物で有れば良く、一般的にはエシェリヒア・コ
リーW3110、エシェリヒア・コリーC600、エシ
ェリヒア・コリーJM109、エシェリヒア・コリーH
B101などを用いることができる。[0021] As the host microorganism, it is sufficient that the recombinant vector is capable of stable and autonomous growth and capable of expressing a foreign gene. Generally, Escherichia coli W3110, Escherichia coli C600, Escherichia collie JM109, Escherichia collie H
B101 or the like can be used.
【0022】宿主微生物に組換えベクターを移入する方
法としては、例えば宿主微生物がエシェリヒア・コリー
属に属する微生物の場合には、カルシウム処理によるコ
ンピテントセル法やエレクトロポレーション法などを用
いることができる。こうして得られた形質転換体である
微生物は栄養培地で培養されることにより、多量のホス
ホエノールピルビン酸カルボキシラーゼを安定に生産し
得ることを見いだした。宿主微生物への目的組換えベク
ター移入の有無についての選択は、目的とするDNAを
保持するベクターの薬剤耐性マーカーとアセチルCoA
などの活性化剤を必要としないホスホエノールピルビン
酸カルボキシラーゼ活性とを同時に発現する微生物を検
索すれば良く、例えば薬剤耐性マーカーに基づく選択培
地で生育し、且つ活性化剤を必要としないホスホエノー
ルピルビン酸カルボキシラーゼを生成する微生物を選択
すれば良い。As a method for introducing the recombinant vector into the host microorganism, for example, when the host microorganism is a microorganism belonging to the genus Escherichia coli, the competent cell method by calcium treatment or the electroporation method can be used. . It was found that the thus obtained transformant microorganism can stably produce a large amount of phosphoenolpyruvate carboxylase by culturing in a nutrient medium. The selection as to whether or not the target recombinant vector is transferred into the host microorganism is carried out by selecting the drug resistance marker of the vector carrying the target DNA and acetyl CoA.
It is only necessary to search for a microorganism that simultaneously expresses a phosphoenolpyruvate carboxylase activity that does not require an activator such as phosphoenolpyruvine that grows in a selective medium based on a drug resistance marker and does not require an activator. A microorganism that produces acid carboxylase may be selected.
【0023】上記の方法により得られたホスホエノール
ピルビン酸カルボキシラーゼ遺伝子の塩基配列はサイエ
ンス(Science), 214, 1205〜1210(1981)に記載されたジ
デオキシ法で解読し、またホスホエノールピルビン酸カ
ルボキシラーゼのアミノ酸配列は塩基配列より推定し
た。このようにして一度選択されたホスホエノールピル
ビン酸カルボキシラーゼ遺伝子を保有する組換えベクタ
ーは、形質転換微生物から取り出され、他の微生物に移
入することも容易に実施できる。また、ホスホエノール
ピルビン酸カルボキシラーゼ遺伝子を保持する組換えベ
クターから制限酵素などによりホスホエノールピルビン
酸カルボキシラーゼ遺伝子であるDNAを切り出し、こ
れを同様な方法により切断して得られるベクター断片と
結合させて、宿主微生物に移入することも容易に実施で
きる。The nucleotide sequence of the phosphoenolpyruvate carboxylase gene obtained by the above method was deciphered by the dideoxy method described in Science, 214, 1205-1210 (1981). The amino acid sequence was deduced from the base sequence. The recombinant vector carrying the phosphoenolpyruvate carboxylase gene thus selected once can be easily taken out from the transformed microorganism and transferred to another microorganism. In addition, a DNA which is a phosphoenolpyruvate carboxylase gene is excised from a recombinant vector having a phosphoenolpyruvate carboxylase gene by a restriction enzyme and the like, and the fragment is ligated with a vector fragment obtained by cleaving the DNA by the same method to prepare a host. Transfer to microorganisms is also easy.
【0024】形質転換体である宿主微生物の培養形態
は、宿主の栄養生理的性質を考慮して培養条件を選択す
れば良く、通常多くの場合は液体培養で行うが、工業的
には通気撹拌培養を行うのが有利である。培地の炭素源
としては、微生物の培養に通常用いられる物が広く使用
され得る。宿主微生物が資化可能で有れば良く、例えば
グルコース、シュークロース、ラクトース、マルトー
ス、フラクトース、糖蜜、ピルビン酸などが使用でき
る。窒素源としては、宿主微生物が利用可能な窒素化合
物で有れば良く、例えばペプトン、肉エキス、カゼイン
加水分解物、大豆粕アルカリ抽出物のような有機窒素化
合物や、硫安、塩安のような無機窒素化合物が使用でき
る。その他、リン酸塩、炭酸塩、硫酸塩、マグネシウ
ム、カルシウム、カリウム、鉄、マンガン、亜鉛などの
塩類、特定のアミノ酸、特定のビタミンなどが必要に応
じて使用できる。The culturing form of the host microorganism which is a transformant may be selected by considering the culturing conditions in consideration of the nutritional physiological properties of the host. Usually, in most cases liquid culture is carried out, but industrially aeration stirring It is advantageous to carry out culturing. As the carbon source of the medium, those usually used for culturing microorganisms can be widely used. It is sufficient that the host microorganism can assimilate, and for example, glucose, sucrose, lactose, maltose, fructose, molasses, pyruvic acid and the like can be used. The nitrogen source may be any nitrogen compound that can be utilized by the host microorganism, for example, organic nitrogen compounds such as peptone, meat extract, casein hydrolyzate and soybean meal alkali extract, and ammonium sulfate and ammonium salt. Inorganic nitrogen compounds can be used. In addition, salts such as phosphates, carbonates, sulfates, magnesium, calcium, potassium, iron, manganese and zinc, specific amino acids, specific vitamins and the like can be used as necessary.
【0025】培養温度は宿主微生物が発育し、ホスホエ
ノールピルビン酸カルボキシラーゼを生産する範囲で適
宜変更し得るが、エシェリヒア・コリーの場合、好まし
くは20〜42℃程度である。培養時間は、培養条件に
より多少変動するが、ホスホエノールピルビン酸カルボ
キシラーゼが最高収量に達する時期を見計らって適当時
期に培養を終了すれば良く、通常は20〜48時間程度
である。培地pHは宿主微生物が発育し、ホスホエノー
ルピルビン酸カルボキシラーゼを生産する範囲内で適宜
変更し得るが、通常好ましくはpH6.0〜9.0程度
である。培養液より菌体を回収する方法は、通常用いら
れる方法により行えば良く、例えば遠心分離、濾過など
によって回収することができる。培養液中のホスホエノ
ールピルビン酸カルボキシラーゼが菌体外に分泌される
場合は、この菌体分離液を用いれば良く、以下の菌体破
砕後の方法に準じてホスホエノールピルビン酸カルボキ
シラーゼを分離精製できる。ホスホエノールピルビン酸
カルボキシラーゼが菌体内に存在する場合、前述したよ
うな酵素的または物理的な破砕方法によって破砕抽出す
ることができる。このようにして得られたホスホエノー
ルピルビン酸カルボキシラーゼ含有溶液は親水性ポリマ
ー、例えばポリエチレンイミン処理により除核酸を行
い、次いで硫安沈澱によりホスホエノールピルビン酸カ
ルボキシラーゼ画分を回収する。この粗酵素液を通常用
いる方法、例えば半透膜を用いた透析や Sephadex G-25
(ファルマシアLKB )ゲル濾過などにより脱塩を行うこ
とができる。この操作の後、酵素溶液を各種のクロマト
グラフィーの組み合わせ、好ましくはDEAEセファロ
ースCL-6B (ファルマシアLKB )、ブチル・トヨパール
650M(東洋曹達)カラムクロマトグラフィーにより分離
精製し、精製酵素標品を得ることができる。この精製酵
素標品は、SDS-PAGE電気泳動でほぼ単一バンドを示す程
度に純化されている。The culturing temperature can be appropriately changed within the range where the host microorganism grows and produces phosphoenolpyruvate carboxylase, but in the case of Escherichia coli, it is preferably about 20 to 42 ° C. Although the culturing time varies somewhat depending on the culturing conditions, it may be completed at a suitable time in consideration of the time when the maximum yield of phosphoenolpyruvate carboxylase is reached, and it is usually about 20 to 48 hours. The pH of the medium can be appropriately changed within the range where the host microorganism grows and produces phosphoenolpyruvate carboxylase, but it is usually preferably about pH 6.0 to 9.0. The cells can be collected from the culture broth by a commonly used method, for example, centrifugation or filtration. When phosphoenolpyruvate carboxylase in the culture medium is secreted outside the cells, this cell separation solution may be used, and phosphoenolpyruvate carboxylase can be separated and purified according to the method after cell disruption below. . When phosphoenolpyruvate carboxylase is present in the cells, it can be crushed and extracted by the enzymatic or physical crushing method described above. The phosphoenolpyruvate carboxylase-containing solution thus obtained is treated with a hydrophilic polymer such as polyethyleneimine to remove nucleic acid, and then the phosphoenolpyruvate carboxylase fraction is recovered by ammonium sulfate precipitation. This crude enzyme solution is usually used, for example, dialysis using a semipermeable membrane or Sephadex G-25.
(Pharmacia LKB) Desalination can be performed by gel filtration or the like. After this operation, the enzyme solution is combined with various chromatographies, preferably DEAE Sepharose CL-6B (Pharmacia LKB), Butyl Toyopearl.
A purified enzyme preparation can be obtained by separation and purification by 650M (Toyo Soda) column chromatography. This purified enzyme preparation was purified to the extent that it showed almost a single band on SDS-PAGE electrophoresis.
【0026】本発明のホスホエノールピルビン酸カルボ
キシラーゼ活性を有する蛋白質は、以下に示す性質を有
する。 (1)作用:以下の反応を触媒する。The protein having phosphoenolpyruvate carboxylase activity of the present invention has the following properties. (1) Action: It catalyzes the following reaction.
【0027】ホスホエノールピルビン酸 + HCO3
- → オキザロ酢酸 + HPO4 2- Phosphoenolpyruvate + HCO 3
- → Oxaloacetate + HPO 4 2-
【0028】(2)至適作用pH:7.5〜8.0 (3)pH安定性:pH5.0〜8.0(25℃、24
時間処理) pH7.5〜8.5(10mM MgSO4 を含むトリ
ス緩衝液中で25℃、24時間処理) (4)至適温度:60℃ (5)熱安定性:45℃以下(pH7.0,15分処
理) (6)分子量:390,000±10,000(ゲル濾
過法) 100,000±5,000(SDS−PAGE) (7)比活性:110単位/mg蛋白 (8)アセチルCoAで活性化されない。(2) Optimum action pH: 7.5 to 8.0 (3) pH stability: pH 5.0 to 8.0 (25 ° C, 24
Time treatment) pH 7.5-8.5 (treatment in Tris buffer containing 10 mM MgSO4 at 25 ° C for 24 hours) (4) Optimum temperature: 60 ° C (5) Thermal stability: 45 ° C or less (pH 7.0) , Treatment for 15 minutes) (6) Molecular weight: 390,000 ± 10,000 (gel filtration method) 100,000 ± 5,000 (SDS-PAGE) (7) Specific activity: 110 units / mg protein (8) Acetyl CoA Not activated by.
【0029】該酵素はアセトバクター・ハンゼニイIFO
14820 が生産する酵素と比べて、炭酸ガス測定用試薬中
の安定性及び比活性において異なっている。すなわち、
アセトバクター・ハンゼニイIFO 14820 の生産する酵素
は、比活性84単位/mg蛋白、炭酸ガス測定用試薬中
の25℃、7日保存後の活性残存率が約30%であるの
に対し、本発明のホスホエノールピルビン酸カルボキシ
ラーゼ活性を有する蛋白質は、比活性が110単位/m
g蛋白、炭酸ガス測定用試薬中にて25℃、7日保存後
の活性残存率は約95%である。The enzyme is Acetobacter hansenii IFO
Compared with the enzyme produced by 14820, it differs in stability and specific activity in the reagent for measuring carbon dioxide. That is,
The enzyme produced by Acetobacter hansenii IFO 14820 has a specific activity of 84 units / mg protein and a residual activity ratio of about 30% after storage in a reagent for measuring carbon dioxide at 25 ° C. for 7 days. The protein having a phosphoenolpyruvate carboxylase activity of 110 has a specific activity of 110 units / m 2.
The activity residual rate after storage for 7 days at 25 ° C. in a reagent for measuring g protein and carbon dioxide is about 95%.
【0030】[0030]
【実施例】以下、本発明を実施例により具体的に説明す
る。実施例中、ホスホエノールピルビン酸カルボキシラ
ーゼの活性測定は以下のようにして行った。すなわち、
50mMTris−HCl(pH8.0)、10mM
Na2 CO3 、3.2mM ホスホエノールピルビン酸
カリウム塩、10mM MgSO4 、0.14mM N
ADH、10U/ml マレートデヒドロゲナーゼを含
む反応混液2.9mlをキュベット(d=1cm)に調
製し、30℃で約5分間予備加温する。次に酵素溶液
0.1mlを添加し緩やかに混和後、水を対照に30℃
に制御された分光光度計で340nmの吸光度変化を2
〜3分間記録し、その初期直線部分から1分間当たりの
吸光度変化を求める(ΔODtest)。盲検は酵素溶
液の代わり50mMリン酸カリウム緩衝液、pH7.0
を加え、同様に操作を行って、1分間当たりの吸光度変
化を求める(ΔODblank)。ホスホエノールピル
ビン酸カルボキシラーゼの活性は、上記条件で1分間当
たり1マイクロモルのNADHを消費する酵素量を1単
位(U)とする。EXAMPLES The present invention will be specifically described below with reference to examples. In the examples, the phosphoenolpyruvate carboxylase activity was measured as follows. That is,
50 mM Tris-HCl (pH 8.0), 10 mM
Na 2 CO 3 , 3.2 mM phosphoenolpyruvate potassium salt, 10 mM MgSO 4 , 0.14 mM N
2.9 ml of a reaction mixture containing ADH and 10 U / ml malate dehydrogenase is prepared in a cuvette (d = 1 cm), and preheated at 30 ° C. for about 5 minutes. Next, 0.1 ml of enzyme solution was added and mixed gently, and water was used as a control at 30 ° C.
Change the absorbance at 340 nm with a spectrophotometer controlled to 2
Record for ~ 3 minutes and determine the change in absorbance per minute from the initial linear portion (ΔODtest). In the blind test, instead of the enzyme solution, 50 mM potassium phosphate buffer, pH 7.0
Is added and the same operation is performed to determine the change in absorbance per minute (ΔODblank). Regarding the activity of phosphoenolpyruvate carboxylase, the amount of the enzyme that consumes 1 micromol NADH per minute under the above-mentioned conditions is 1 unit (U).
【0031】参考例1アセトバクター・ハンゼニイIFO14820株からの
ホスホエノールピルビン酸カルボキシラーゼの精製 ホスホエノールピルビン酸カルボキシラーゼ生産菌アセ
トバクター・ハンゼニイIFO 14820 を10Lジャーファ
ーメンターで培養した。培地組成はポリペプトン0.5
%、酵母エキス0.5%、グルコース0.5%、硫酸マ
グネシウム0.5%を含む培地(pH7.0)100m
lを500ml容坂口フラスコに移し、121℃、15
分間オートクレーブを行った。種菌としてアセトバクタ
ー・ハンゼニイIFO 14820 を1白金耳植菌し、30℃、
48時間培養し、種培養液とした。次に培地6Lを10
L容ジャーファーメンターに移し121℃、15分間オ
ートクレーブを行い、放令後種培養液を100mlを移
し、300rpm、通気2L/分、30℃で48時間培
養した。この時の培養液中のホスホエノールピルビン酸
カルボキシラーゼ活性は0.2U/mlであった。Reference Example 1 From Acetobacter hansenii IFO 14820 strain
Purification of phosphoenolpyruvate carboxylase Phosphoenolpyruvate carboxylase-producing bacterium Acetobacter hansenii IFO 14820 was cultured in a 10 L jar fermenter. Medium composition is polypeptone 0.5
%, Yeast extract 0.5%, glucose 0.5%, magnesium sulfate 0.5%, medium (pH 7.0) 100 m
1 to a 500 ml Sakaguchi flask, 121 ° C, 15
It was autoclaved for a minute. Acetobacter hansenii IFO 14820 was inoculated as an inoculum with 1 platinum loop, at 30 ℃,
It was cultured for 48 hours to obtain a seed culture solution. Next, add 6 L of medium to 10
The mixture was transferred to an L-volume jar fermenter and autoclaved at 121 ° C. for 15 minutes. After release, 100 ml of the seed culture solution was transferred and cultured at 300 rpm, aeration 2 L / min, and 30 ° C. for 48 hours. The phosphoenolpyruvate carboxylase activity in the culture medium at this time was 0.2 U / ml.
【0032】培養液を遠心分離にて集菌し、50mMリ
ン酸カリウム緩衝液、pH7.0に懸濁した。本液をフ
レンチプレスで処理し、遠心分離を行い、ホスホエノー
ルピルビン酸カルボキシラーゼ粗酵素画分を得た。得ら
れた粗酵素画分は硫安分画後、セファデックス G-25
(ファルマシアLKB)ゲル濾過にて脱塩した後、DEAE
セファロースCL-6B (ファルマシアLKB )、ハイドロキ
シルアパタイト(生化学工業株式会社)、セファデック
ス G-200ゲル濾過(ファルマシアLKB )、MonoP HR5/5
クロマトフォーカシング(ファルマシアLKB )の4種の
クロマトグラフィーを行った。このホスホエノールピル
ビン酸カルボキシラーゼ標品は、SDS-PAGE電気泳動で均
一なバンドを示すまで精製されていた。この時のホスホ
エノールピルビン酸カルボキシラーゼの比活性は84U
/mg蛋白であった。下記表1にこれまでの精製のまと
めを示す。また表2に上記方法により得られたホスホエ
ノールピルビン酸カルボキシラーゼの理化学的性質を示
す。The culture broth was collected by centrifugation and suspended in 50 mM potassium phosphate buffer, pH 7.0. This solution was treated with a French press and centrifuged to obtain a crude enzyme fraction of phosphoenolpyruvate carboxylase. The crude enzyme fraction thus obtained was subjected to Sephadex G-25 after ammonium sulfate fractionation.
(Pharmacia LKB) After desalting by gel filtration, DEAE
Sepharose CL-6B (Pharmacia LKB), Hydroxyl apatite (Seikagaku Corporation), Sephadex G-200 gel filtration (Pharmacia LKB), MonoP HR5 / 5
Four types of chromatography, chromatofocusing (Pharmacia LKB), were performed. The phosphoenolpyruvate carboxylase preparation was purified until it showed a uniform band on SDS-PAGE. The specific activity of phosphoenolpyruvate carboxylase at this time is 84U.
/ Mg protein. Table 1 below shows a summary of the purification so far. Table 2 shows the physicochemical properties of phosphoenolpyruvate carboxylase obtained by the above method.
【0033】[0033]
【表1】 [Table 1]
【0034】[0034]
【表2】 [Table 2]
【0035】実施例1染色体DNAの分離 アセトバクター・ハンゼニイ IFO 14820の染色体DNA
は、以下の方法で分離した。同菌株を150mlの普通
ブイヨン培地、pH5.0で30℃、48時間振盪培養
後、遠心分離(8000rpm、10分間)により集菌
した。10%シュークロース、50mM Tris−H
Cl、pH8.0、50mM EDTAを含んだ溶液5
mlに懸濁し、1mlのリゾチーム溶液(10mg/m
l)を加えて37℃、15分間保温し、次いで10%S
DS溶液を加えた。この溶液に等量のクロロホルム・フ
ェノール(1:1)を加え、撹拌混合し、10,000
rpm、3分間の遠心分離で水層と溶媒層に分離し、水
層を分取した。この水層に2倍量のエタノールを静かに
重層し、ガラス棒でゆっくり撹拌しながらDNAをガラ
ス棒に巻き付かせて分離した。これを1mM EDTA
を含んだ10mM Tris−HCl、pH8.0(以
下TEと略記)で溶解した。これを等量のクロロホルム
・フェノール溶液で処理後、遠心分離により水層を分取
し、2倍量のエタノールを加えて、上記の方法により再
度DNAを分離し、2mlのTEで溶解した。エシェリ
ヒア・コリーJM109のコンピテントセルは Hanahan
の方法により作成し、ライブラリー作成の宿主とした。[0035] Chromosomal DNA isolation Acetobacter Hanzenii IFO fourteen thousand eight hundred twenty of Example 1 Chromosomal DNA
Were separated by the following method. The strain was cultured with shaking in 150 ml of a normal broth medium at pH 5.0 at 30 ° C. for 48 hours and then collected by centrifugation (8000 rpm, 10 minutes). 10% sucrose, 50 mM Tris-H
Solution 5 containing Cl, pH 8.0, 50 mM EDTA 5
1 ml lysozyme solution (10 mg / m
l) was added and incubated at 37 ° C for 15 minutes, then 10% S
The DS solution was added. To this solution, add an equal volume of chloroform / phenol (1: 1), stir and mix, and add 10,000
The aqueous layer and the solvent layer were separated by centrifugation at rpm for 3 minutes, and the aqueous layer was separated. The aqueous layer was gently overlaid with 2 volumes of ethanol, and the DNA was wound around the glass rod while gently stirring with a glass rod to separate the DNA. This is 1 mM EDTA
It was dissolved in 10 mM Tris-HCl, pH 8.0 (hereinafter abbreviated as TE) containing After treating this with an equal volume of chloroform / phenol solution, the aqueous layer was separated by centrifugation, twice the amount of ethanol was added, the DNA was separated again by the above method, and dissolved with 2 ml TE. Escherichia Collie JM109 competent cell is Hanahan
Was prepared by the method described above and used as a host for library preparation.
【0036】ホスホエノールピルビン酸カルボキシラー
ゼをコードする遺伝子を含有するDNA断片を有する組
換えベクターの調製 上記方法で得たDNA20μgを制限酵素Sau3AII
I (東洋紡製)で部分分解した後、シュークロース密度
勾配遠心法にて3〜10kbpの断片を分離回収し、エ
タノール沈澱にて濃縮後、TEにて1μg/μlになる
ように再溶解した。このDNA断片1μgを、SalII
I (東洋紡製)で切断したpUC190.5μgと M.
G.Loftusらの Backfilling法 (Biotechniques Vol. 12,
No.2(1992)に従い、T4DNAリガーゼ(東洋紡製)
1ユニットで16℃、12時間反応させDNAを連結し
た。連結したDNAはエシェリヒア・コリーJM109
のコンピテントセルを用いて形質転換した。使用したD
NA1μg当たり約1×105個の形質転換体のコロニ
ーが得られた。 Phosphoenolpyruvate Carboxyler
Set having a DNA fragment containing a gene encoding ze
Preparation of recombinant vector 20 μg of the DNA obtained by the above method was added to the restriction enzyme Sau3AII.
After partial decomposition with I (manufactured by Toyobo Co., Ltd.), a 3-10 kbp fragment was separated and collected by a sucrose density gradient centrifugation method, concentrated by ethanol precipitation, and redissolved by TE to a concentration of 1 μg / μl. 1 μg of this DNA fragment was added to SalII
PUC190.5 μg cut with I (manufactured by Toyobo) and M.
Backfilling method of G. Loftus et al. (Biotechniques Vol. 12,
According to No. 2 (1992), T4 DNA ligase (Toyobo)
The DNA was ligated by reacting with 1 unit at 16 ° C. for 12 hours. The ligated DNA is Escherichia coli JM109.
Transformation was performed using the competent cells of. Used D
About 1 × 10 5 transformant colonies were obtained per 1 μg of NA.
【0037】ホスホエノールピルビン酸カルボキシラー
ゼ遺伝子をコードするDNA断片を含有する形質転換体
のスクリーニング 上記方法で得た形質転換体よりホスホエノールピルビン
酸カルボキシラーゼ遺伝子を含有するDNA断片を含む
形質転換体のスクリーニングは、アセトバクター・ハン
ゼニイIFO 14820 由来のホスホエノールピルビン酸カル
ボキシラーゼに特異的な抗体を用いた酵素免疫テストに
より行った。アセトバクター・ハンゼニイIFO 14820 由
来のホスホエノールピルビン酸カルボキシラーゼ抗体及
び抗体への酵素標識の調製は常法に従い、以下のように
行った。アセトバクター・ハンゼニイIFO 14820 由来ホ
スホエノールピルビン酸カルボキシラーゼを免疫した兎
の血清10mlをプロテインA-セファロース CL-6B(フ
ァルマシアLKB )にて精製を行い、IgG画分を回収し
た。次いでこのIgG8mgとペルオキダーゼ(東洋紡
製)5mgを新ナカネ法によりIgG−ペルオキシダー
ゼコンジュゲートを作成し、TSK G3000SW (東洋曹達)
ゲル濾過により精製を行った。上記方法により得られた
IgG−ペルオキダーゼコンジュゲートは0.1ngの
ホスホエノールピルビン酸カルボキシラーゼ蛋白質を検
出できる感度を有しており、更にエシェリヒア・コリー
由来のホスホエノールピルビン酸カルボキシラーゼには
反応しなかった。上記方法により得たホスホエノールピ
ルビン酸カルボキシラーゼ抗体−ペルオキダーゼコンジ
ュゲートを用いたホスホエノールピルビン酸カルボキシ
ラーゼ遺伝子のスクリーニングの方法は以下の通りに行
った。 Phosphoenolpyruvate carboxylate
Transformant containing a DNA fragment encoding the ze gene
Screening of transformants containing a DNA fragment containing the phosphoenolpyruvate carboxylase gene from the transformants obtained by the method described above was carried out using an antibody specific to phosphoenolpyruvate carboxylase derived from Acetobacter hansenii IFO 14820. The enzyme immunoassay used was used. The preparation of the phosphoenolpyruvate carboxylase antibody derived from Acetobacter hansenii IFO 14820 and the enzyme label on the antibody was carried out in the following manner according to a conventional method. 10 ml of the serum of a rabbit immunized with phosphoenolpyruvate carboxylase derived from Acetobacter hansenii IFO 14820 was purified with protein A-Sepharose CL-6B (Pharmacia LKB) to collect an IgG fraction. Next, 8 mg of this IgG and 5 mg of peroxidase (manufactured by Toyobo) were used to prepare an IgG-peroxidase conjugate by the new Nakane method, and TSK G3000SW (Toyo Soda)
Purification was performed by gel filtration. The IgG-peroxidase conjugate obtained by the above method has a sensitivity capable of detecting 0.1 ng of phosphoenolpyruvate carboxylase protein and does not react with phosphoenolpyruvate carboxylase derived from Escherichia coli. It was The method for screening the phosphoenolpyruvate carboxylase gene using the phosphoenolpyruvate carboxylase antibody-peroxidase conjugate obtained by the above method was performed as follows.
【0038】上記方法で得た形質転換体のコロニーは、
ホスホエノールピルビン酸カルボキシラーゼ抗体で被覆
したビニールシートにレプリカした後、37℃で終夜培
養し再度コロニーを形成した後マスタープレートとして
保存した。一方、レプリカしたビニールシート上の菌体
はクロロホルム蒸気に約20分間さらして溶菌した。溶
菌操作の後、0.1%BSAを含んだ10mM PBS
(2.3mM KH2PO4 ,7.7mM Na2 HP
O4 ・12H2 O,150mM NaCl,pH7.
2)にて洗浄し菌体残渣を除去した。このビニールシー
トを0.1%のホスホエノールピルビン酸カルボキシラ
ーゼ抗体−ペルオキダーゼコンジュゲートと0.1%の
BSAを含んだ10mM PBSに室温で3時間浸漬し
た。次いで0.1%のBSAと0.05%のTween
20を含んだPBSにて洗浄し、更に蒸留水にて洗浄を
行った後、風乾した。この風乾後のビニールシートをペ
ルオキシダーゼ用の発色基質を含んだゼラチンプレート
(3mg/ml 3,3'-5,5'- テトラメチルベンチジン、
10mg/mlジオクチル・ソジウム・サルフェート、
0.4g/mlゼラチン、50%メタノール、50mM
クエン酸緩衝液、pH5.0)上にのせ、緑色に発色
するスポットを検出した。この発色したスポットとマス
タープレート上のコロニーの位置とを照合し、一致する
コロニーをホスホエノールピルビン酸カルボキシラーゼ
遺伝子含んだ形質転換株として選択した。The transformant colonies obtained by the above method are
After replicating on a vinyl sheet coated with phosphoenolpyruvate carboxylase antibody, it was cultured at 37 ° C. overnight to form colonies again, and then stored as a master plate. On the other hand, the bacterial cells on the replicated vinyl sheet were exposed to chloroform vapor for about 20 minutes to lyse them. After lysis procedure, 10 mM PBS containing 0.1% BSA
(2.3 mM KH 2 PO 4 , 7.7 mM Na 2 HP
O 4 .12H 2 O, 150 mM NaCl, pH 7.
The cells were washed in 2) to remove the cell residue. This vinyl sheet was immersed in 10 mM PBS containing 0.1% phosphoenolpyruvate carboxylase antibody-peroxidase conjugate and 0.1% BSA at room temperature for 3 hours. Then 0.1% BSA and 0.05% Tween
It was washed with PBS containing 20 and further with distilled water, and then air-dried. The air-dried vinyl sheet was used as a gelatin plate (3 mg / ml 3,3'-5,5'-tetramethylbenzidine, containing a color-developing substrate for peroxidase,
10 mg / ml dioctyl sodium sulphate,
0.4 g / ml gelatin, 50% methanol, 50 mM
It was placed on a citrate buffer solution (pH 5.0), and a spot that developed a green color was detected. The colored spots were compared with the positions of the colonies on the master plate, and the matching colonies were selected as transformants containing the phosphoenolpyruvate carboxylase gene.
【0039】以上の方法により、形質転換株約2万株を
スクリーニングした結果、2個の抗体陽性株を取得し
た。この2株よりプラスミドを抽出し制限酵素地図を作
成した結果、共通した約2.7kbpのDNA断片を確
認した。As a result of screening about 20,000 transformants by the above method, two antibody-positive strains were obtained. As a result of extracting a plasmid from these two strains and creating a restriction enzyme map, a common DNA fragment of about 2.7 kbp was confirmed.
【0040】塩基配列の決定 上記方法で得られた組換えプラスミドの内、挿入DNA
の小さかったプラスミドをpEPC11と命名し、その
挿入DNA(約4.2kbp)について塩基配列の決定
を行った。種々のサブクローン及びデリィーションミュ
ータントは常法に従い、Nonradioactive Sequencing ki
t (東洋紡製)を用いて決定した。決定した塩基配列及
びアミノ酸配列を配列表・配列番号1及び2に示した。
アミノ酸配列から求められる蛋白質の分子量は約10
3,000であり、アセトバクター・ハンゼニイ IFO 1
4820のホスホエノールピルビン酸カルボキシラーゼの分
子量(約100,000)と良く一致した。 Determination of nucleotide sequence Among the recombinant plasmids obtained by the above method, the inserted DNA
The plasmid having a small DNA size was designated as pEPC11, and the nucleotide sequence of the inserted DNA (about 4.2 kbp) was determined. Various subclones and deletion mutants were prepared according to the standard method using Nonradioactive Sequencing
t (manufactured by Toyobo). The determined nucleotide sequence and amino acid sequence are shown in Sequence Listing and SEQ ID NOs: 1 and 2.
The molecular weight of the protein determined from the amino acid sequence is about 10
3,000 and the Acetobacter Hansenii IFO 1
It was in good agreement with the molecular weight of phosphoenolpyruvate carboxylase of 4820 (about 100,000).
【0041】エシェリヒア・コリー形質転換体の作成 pEPC11でエシェリヒア・コリーJM109のコン
ピテントセルを形質転換後、形質転換体エシェリヒア・
コリーJM109(pEPC11)を得た。Preparation of Escherichia coli Transformant After transforming competent cells of Escherichia coli JM109 with pEPC11, transformant Escherichia coli.
Cory JM109 (pEPC11) was obtained.
【0042】ホスホエノールピルビン酸カルボキシラー
ゼの製造 TB培地(1.2%バクトトリプトン、2.4%バクト
イーストエキストラクト、0.4%グリセロール、17
mM KH2 PO4 、72mM K2 HPO4)6Lを
10L−ジャーファーメンターに分注し、121℃、1
5分間オートクレーブを行い放冷後、別途無菌濾過した
50mg/mlアンピシリン(ナカライテスク製)及び
100mM イソプロピル−1−チオ−β−D−ガラク
トシド(IPTG、日本精化製)をそれぞれ6ml添加
した。この培地にLB培地(1%バクトトリプトン、
0.5%バクトイーストエキストラクト、1.0%Na
Cl,pH7.4)で予め30℃、16時間振盪培養し
たエシェリヒア・コリーJM109(pEPC11)の
培養液60mlを接種し、30℃、24時間通気撹拌培
養した。培養終了時の培養液のホスホエノールピルビン
酸カルボキシラーゼ活性は5.4U/mlであった。培
養液6Lを遠心分離にて集菌し、3Lの20mM リン
酸カリウム緩衝液、pH7.0に懸濁し、常法に従いフ
レンチプレスで破砕した後、8,000rpm20分間
遠心分離してホスホエノールピルビン酸カルボキシラー
ゼ粗酵素液を得た。このようにして得た粗酵素液をポリ
エチレンイミンを用いて除核酸処理をした後、硫安沈澱
によりホスホエノールピルビン酸カルボキシラーゼ画分
を回収した。次いでセファデックス G-25 (ファルマシ
アLKB )ゲル濾過により脱塩を行った後、DEAEセフ
ァロース CL-6B(ファルマシアLKB )カラムクロマトグ
ラフィー、ブチル・トヨパール650Mカラムクロマトグラ
フィーを行い、硫安沈澱によって濃縮して精製ホスホエ
ノールピルビン酸カルボキシラーゼ標品を得た。このホ
スホエノールピルビン酸カルボキシラーゼ精製標品は、
SDS−PAGE電気泳動で単一のバンドを示し、活性
回収率は33.2%であった。下記表3にこれまでの精
製のまとめを示す。また表4に上記方法により得られた
ホスホエノールピルビン酸カルボキシラーゼの理化学的
性質を示す。 Phosphoenolpyruvate carboxylate
Preparation of TB medium (1.2% bactotryptone, 2.4% bacto yeast extract, 0.4% glycerol, 17%
6 L of mM KH 2 PO 4 , 72 mM K 2 HPO 4 ) was dispensed into a 10 L-jar fermenter, and 121 ° C., 1
After autoclaving for 5 minutes and allowing to cool, 6 ml each of 50 mg / ml ampicillin (manufactured by Nacalai Tesque) and 100 mM isopropyl-1-thio-β-D-galactoside (IPTG, manufactured by NIPPON SEIKA CO., LTD.), Which were separately aseptically filtered, were added. LB medium (1% bactotryptone,
0.5% Bacto yeast extract, 1.0% Na
60 ml of a culture solution of Escherichia coli JM109 (pEPC11) which had been shake-cultured with Cl, pH 7.4) at 30 ° C. for 16 hours in advance was inoculated, and the mixture was aerated with stirring at 30 ° C. for 24 hours. The phosphoenolpyruvate carboxylase activity of the culture medium at the end of the culture was 5.4 U / ml. 6 L of the culture solution was collected by centrifugation, suspended in 3 L of 20 mM potassium phosphate buffer, pH 7.0, disrupted by a French press according to a conventional method, and then centrifuged at 8,000 rpm for 20 minutes, and phosphoenolpyruvate. A crude enzyme solution of carboxylase was obtained. The crude enzyme solution thus obtained was treated with polyethyleneimine to remove nucleic acid, and then the phosphoenolpyruvate carboxylase fraction was recovered by ammonium sulfate precipitation. Next, after desalting by Sephadex G-25 (Pharmacia LKB) gel filtration, DEAE Sepharose CL-6B (Pharmacia LKB) column chromatography and Butyl-Toyopearl 650M column chromatography were performed, and the product was concentrated and purified by ammonium sulfate precipitation. A phosphoenolpyruvate carboxylase preparation was obtained. This phosphoenolpyruvate carboxylase purified preparation is
SDS-PAGE electrophoresis showed a single band, and the activity recovery rate was 33.2%. Table 3 below shows a summary of the purification so far. Table 4 shows the physicochemical properties of the phosphoenolpyruvate carboxylase obtained by the above method.
【0043】[0043]
【表3】 [Table 3]
【0044】[0044]
【表4】 [Table 4]
【0045】上記表1と3を比較すれば、本発明のホス
ホエノールピルビン酸カルボキシラーゼは野性株である
アセトバクター・ハンゼニイ IFO 14820の製造法に比べ
簡便な方法により高収率にホスホエノールピルビン酸カ
ルボキシラーゼを回収することができる。また上記表2
と表4を比較すれば、本発明のホスホエノールピルビン
酸カルボキシラーゼが野性株であるアセトバクター・ハ
ンゼニイIFO 14820 由来のホスホエノールピルビン酸カ
ルボキシラーゼより高純度であることが判る。Comparing Tables 1 and 3 above, the phosphoenolpyruvate carboxylase of the present invention shows that the phosphoenolpyruvate carboxylase of the present invention is produced in a high yield in a high yield by a simple method as compared with the method for producing the wild strain Acetobacter hansenii IFO 14820. Can be recovered. Table 2 above
Comparing Table 4 with Table 4, it can be seen that the phosphoenolpyruvate carboxylase of the present invention is of higher purity than the phosphoenolpyruvate carboxylase derived from the wild strain Acetobacter hansenii IFO 14820.
【0046】参考例2エシェリヒア・コリーJM109由来のホスホエノール
ピルビン酸カルボキシラーゼ標品を用いた炭酸ガス測定 実施例1で精製したエシェリヒア・コリーJM109由
来のホスホエノールピルビン酸カルボキシラーゼ標品を
用いて、下記炭酸ガス測定用試薬を作成した。 Tris−HCl,pH8.0 50 mM MgSO4 10 mM ホスホエノールピルビンカリウム塩 3.2 mM NADH 0.5 mM マレートデヒドロゲナーゼ 50 U/ml ホスホエノールピルビン酸カルボキシラーゼ 3 U/ml 上記試薬3mlと重炭酸イオン0〜20mMを含む試料
0.05mlを添加し、37℃で5分間反応させ、34
0nmにおける5分間の吸光度の減少量を測定した(重
炭酸イオン濃度0mMをブランクとして減じた)。試料
中の重炭酸濃度と5分間に吸光度減少量の関係を図1に
示した。重炭酸イオン濃度と吸光度変化の間には直線関
係が存在した。Reference Example 2 Phosphoenols derived from Escherichia coli JM109
Carbon dioxide measurement using a pyruvate carboxylase preparation Using the phosphoenolpyruvate carboxylase preparation derived from Escherichia coli JM109 purified in Example 1, the following reagent for measuring carbon dioxide was prepared. Tris-HCl, pH8.0 50 mM MgSO 4 10 mM phosphoenolpyruvate potassium salt 3.2 mM NADH 0.5 mM malate dehydrogenase 50 U / ml phosphoenolpyruvate carboxylase 3 U / ml the reagent 3ml and bicarbonate ions 0.05 ml of a sample containing 0 to 20 mM was added, and the mixture was reacted at 37 ° C. for 5 minutes.
The amount of decrease in absorbance at 0 nm for 5 minutes was measured (a bicarbonate ion concentration of 0 mM was subtracted as a blank). The relationship between the concentration of bicarbonate in the sample and the amount of decrease in absorbance during 5 minutes is shown in FIG. There was a linear relationship between bicarbonate concentration and absorbance change.
【0047】参考例3エシェリヒア・コリーJM109由来のホスホエノール
ピルビン酸カルボキシラーゼ標品の炭酸ガス測定用試液
中の安定性 比較例1で精製したアセトバクター・ハンゼニイ IFO 1
4820由来のホスホエノールピルビン酸カルボキシラーゼ
標品と実施例1で精製したエシェリヒア・コリーJM1
09由来のホスホエノールピルビン酸カルボキシラーゼ
標品を用いて炭酸ガス測定用試液中の安定性を25℃で
比較した。その結果を図2に示す。図2から明らかなよ
うに、本発明のホスホエノールピルビン酸カルボキシラ
ーゼ標品は野性株であるアセトバクター・ハンゼニイ I
FO 14820由来のホスホエノールピルビン酸カルボキシラ
ーゼに比べ、25℃での保存安定性が有意に向上してい
た。Reference Example 3 Phosphoenols derived from Escherichia coli JM109
Pyruvate carboxylase standard solution for carbon dioxide measurement
Stability in Acetobacter hansenii IFO 1 purified in Comparative Example 1
Phosphoenolpyruvate carboxylase preparation derived from 4820 and Escherichia coli JM1 purified in Example 1
The phosphoenolpyruvate carboxylase preparation derived from 09 was used to compare the stability in a test solution for measuring carbon dioxide at 25 ° C. The result is shown in FIG. As is clear from FIG. 2, the phosphoenolpyruvate carboxylase preparation of the present invention is a wild strain, Acetobacter hansenii I.
The storage stability at 25 ° C was significantly improved as compared to FO 14820-derived phosphoenolpyruvate carboxylase.
【0048】[0048]
【発明の効果】本発明により新規ホスホエノールピルビ
ン酸カルボキシラーゼ遺伝子の塩基配列及びアミノ酸配
列が明かとなり、工業的に大量生産ができるようになっ
た。また、本発明の製法により、野性株により生産され
たホスホエノールピルビン酸カルボキシラーゼに比べ、
高純度のホスホエノールピルビン酸カルボキシラーゼを
高収率で取得することが可能になった。更に、本発明の
製法により取得したホスホエノールピルビン酸カルボキ
シラーゼを用いる事により、安定性にすぐれた炭酸ガス
測定用試薬を作成することが可能となった。INDUSTRIAL APPLICABILITY According to the present invention, the nucleotide sequence and amino acid sequence of the novel phosphoenolpyruvate carboxylase gene have been clarified, and it has become possible to industrially mass-produce it. Further, according to the production method of the present invention, compared to phosphoenolpyruvate carboxylase produced by a wild strain,
It has become possible to obtain high-purity phosphoenolpyruvate carboxylase with high yield. Furthermore, by using the phosphoenolpyruvate carboxylase obtained by the production method of the present invention, it became possible to prepare a reagent for measuring carbon dioxide having excellent stability.
【0049】[0049]
配列番号:1 配列の長さ: 933 配列の型:アミノ酸 トポロジー:直鎖状 配列の種類:タンパク質 起源 生物名:アセトバクター・ハンゼニイ(Acetobacter ha
nsenii) 株名:IFO14820 配列 Met Ser Gln Ala Ser Ala Pro His Ala Thr Asp Met Leu Gln Gln Gln 1 5 10 15 Ala Arg Glu Leu Val Ala Ile Pro Ala Leu Ser Asp Asn Pro Val Met 20 25 30 Thr Leu Ala Arg Ser Ile Gly Gln Gln Ile Asp Arg Gly Ser Leu Ser 35 40 45 Thr Asp Ala Leu Glu Ala Trp Val Arg Arg Leu Arg Asp Ala Ala Phe 50 55 60 Ala Arg Arg Ala Cys His Ile Ala Ala Tyr Val Gly Gly Val Asp Asp 65 70 75 80 Ala Val Ile Asp Gln Arg Met Arg Asp Val Ala Arg Arg Ile Met Gln 85 90 95 Pro Asp Pro Asn Asp Ser Pro Val Pro Ile Ala Arg Phe Arg Ala Ala 100 105 110 Thr Glu Arg Ser Arg Phe Ala Ala Val Phe Thr Ala His Pro Thr Phe 115 120 125 Ala Leu Ala Ser Pro Val Tyr Asp Cys Leu Ala Asp Met Ala Thr Gln 130 135 140 Asn Pro Gln Gln Pro Pro Thr Asp Val Pro Ala Phe Ile Thr His Arg 145 150 155 160 Arg Ala Ala Pro Pro Thr Leu Asp Glu Glu Phe Thr Leu Ala Thr Gln 165 170 175 Ala Ile Leu Arg Gly Arg Asn Ala Leu Asp Arg Leu Thr Arg Val Leu 180 185 190 Leu Thr Glu Ala Arg Ala His Trp Pro Gln Leu Trp Ala Thr Leu Ala 195 200 205 Pro Arg Pro Ile Ile Met Thr Ser Trp Val Gly Tyr Asp Thr Asp Gly 210 215 220 Arg Thr Asp Ile Gly Trp Trp Asp Thr Leu Arg Leu Arg Val Arg Met 225 230 235 240 Lys His Met Gln Leu Thr Arg Leu Asn Ala Gln Ile Gly Pro Val Ala 245 250 255 Ser Val Pro Asn Asp Leu His Glu Arg Val Asn Arg Ala Ile Gln Ala 260 265 270 Val Glu Ala Gln Ile Ala Ala Cys Pro Gly Ser Ala Asp Pro Gln Ala 275 280 285 Val Ala Asp Phe Ala Ala Val Leu Ile Gly Arg Arg Glu Glu Ala Met 290 295 300 Thr Ser Ser Asn Asp Leu Ala Pro Thr Phe Ala Glu Ala Ile Asp Ala 305 310 315 320 Ala Thr Leu Asp Asp Lys Met Thr Leu Ala Val Ala Arg Ala Gly Phe 325 330 335 Met Ala His Gly Leu Ser Ala Ala His Thr His Val Arg Leu Asn Ser 340 345 350 Thr Gln Leu His Asn Val Ala Arg Gln Arg Leu Gly Ile Thr Asp Asn 355 360 365 Pro Asp Ile His Ala Gln Arg Arg Ala Arg Ile Ala Arg Ile Asp Glu 370 375 380 Ala Leu Asp Thr Thr Gln Pro Ile Asp Ile Asp Phe Gly Ser Leu Leu 385 390 395 400 Val Glu Gln Ser Thr Ala Gly Arg Leu Met Met Thr Val Arg Gln Ile 405 410 415 Leu His His Ile Asp Arg Thr Thr Pro Ile Arg Phe Leu Ile Ala Glu 420 425 430 Thr Glu Thr Gly Tyr Thr Leu Leu Thr Ala Leu Trp Leu Ala Arg Leu 435 440 445 Leu Gly Val Glu Asp Met Ile Glu Ile Ser Pro Leu Phe Glu Thr Gln 450 455 460 Asp Ala Leu Glu Gln Gly Glu His Leu Ile Glu Glu Ala Leu His Ser 465 470 475 480 Pro His Trp Arg Ala Tyr Leu His Arg Thr Arg Lys Leu Ser Leu Gln 485 490 495 Phe Gly Phe Ser Asp Ser Gly Arg Tyr Val Gly Gln Leu Ala Ala Thr 500 505 510 Tyr Leu Ile Glu Arg Leu Arg Leu Lys Val Cys Asp Leu Leu Arg Gln 515 520 525 Trp Asp Leu Ala Phe Val Glu Val Ile Leu Phe Asp Thr His Gly Glu 530 535 540 Ser Ile Gly Arg Gly Ala His Pro Tyr Ser Leu Ala Glu Arg Phe Asp 545 550 555 560 Tyr Leu Ser Pro Pro His Ala Arg Met Arg Phe Leu Gln Ala Gly Ile 565 570 575 Arg Leu Arg Glu Glu Thr Ala Phe Gln Gly Gly Asp Gly Tyr Leu Leu 580 585 590 Phe Gly Thr Gln Pro Leu Ala Asp Ala Thr Val Ser Val Ile Ala Glu 595 600 605 His Ala Phe Ala Thr Thr Ser Ile Asp Glu Asp Pro Val Tyr Asp Glu 610 615 620 Pro Asp Phe Ser Ala Asp Phe Phe Ser Ala Ile Ala Arg Gly Met Thr 625 630 635 640 Gly Leu Val Glu Asp Pro Gly Tyr Ala Ala Leu Leu Gly Ala Phe Gly 645 650 655 Pro Ser Leu Ile Asp Lys Thr Gly Ser Arg Pro Ser Ala Arg Gln Ser 660 665 670 Asp Thr Ala Ala Ile Thr Thr Arg Ile Arg His Pro Ser Gln Leu Arg 675 680 685 Ala Ile Pro Asn Asn Ala Ile Leu Gln Gln Leu Gly Trp Cys Ala Asn 690 695 700 Thr Leu Gln Gly Leu Gly Thr Ala Ala Ala Arg His Pro Asp Thr Phe 705 710 715 720 Glu Arg Tyr Leu Asn Asp Ser Pro Arg Phe Arg Arg Ala Leu Asp Phe 725 730 735 Ala Ala His Gly Leu Ala His Ser Ser Asp Gly Val Leu Arg Gly Val 740 745 750 Ile Arg Leu Leu Asp Pro Asp Met Trp Leu Gln Arg Ala Thr Ala His 755 760 765 His Asp Pro Lys Arg Gln Asp Ala Cys Leu Thr Leu Met His Gly Leu 770 775 780 Glu Arg Leu Asp Phe Trp Ala Cys Thr Gln Ser Met Phe Arg Arg Leu 785 790 795 800 Gln Ser Asp His Leu Ala Leu Arg Asn Ala Trp Pro Ser Ala Pro Arg 805 810 815 Met Glu Ala Asp Glu Met Leu Leu His Ala Ile Arg Ile Ala Ile Ile 820 825 830 Glu Gln Ile Trp Met Leu Ser Thr Arg Ile Pro Tyr Phe Ala Pro Arg 835 840 845 Asn Ala Phe Thr Arg Asp Val Leu Thr Ala Lys Val Leu Cys Leu Glu 850 855 860 Ile Pro Asp Val Leu Lys Glu Leu Glu His Ile Phe Pro Tyr His Ala 865 870 875 880 Asp Arg Ser Phe Asp Leu Asp Phe His Glu Pro His Gly Pro Arg Asp 885 890 895 Glu Gly Thr Tyr Met Arg Glu Tyr Thr Glu Ile Phe Glu Pro Met Gln 900 905 910 Arg Leu Phe Thr Leu Val Arg Glu Ile Ser Thr Gly Val Met His His 915 920 925 Val Gly Ala Phe Gly 930 933 SEQ ID NO: 1 Sequence length: 933 Sequence type: Amino acid Topology: Linear Sequence type: Protein Origin organism name: Acetobacter hanzeni
nsenii) Strain name: IFO14820 Sequence Met Ser Gln Ala Ser Ala Pro His Ala Thr Asp Met Leu Gln Gln Gln 1 5 10 15 Ala Arg Glu Leu Val Ala Ile Pro Ala Leu Ser Asp Asn Pro Val Met 20 25 30 Thr Leu Ala Arg Ser Ile Gly Gln Gln Ile Asp Arg Gly Ser Leu Ser 35 40 45 Thr Asp Ala Leu Glu Ala Trp Val Arg Arg Leu Arg Asp Ala Ala Phe 50 55 60 Ala Arg Arg Ala Cys His Ile Ala Ala Tyr Val Gly Gly Val Asp Asp 65 70 75 80 Ala Val Ile Asp Gln Arg Met Arg Asp Val Ala Arg Arg Ile Met Gln 85 90 95 Pro Asp Pro Asn Asp Ser Pro Val Pro Ile Ala Arg Phe Arg Ala Ala 100 105 110 Thr Glu Arg Ser Arg Phe Ala Ala Val Phe Thr Ala His Pro Thr Phe 115 120 125 Ala Leu Ala Ser Pro Val Tyr Asp Cys Leu Ala Asp Met Ala Thr Gln 130 135 140 Asn Pro Gln Gln Pro Pro Thr Asp Val Pro Ala Phe Ile Thr His Arg 145 150 155 160 Arg Ala Ala Pro Pro Thr Leu Asp Glu Glu Phe Thr Leu Ala Thr Gln 165 170 175 Ala Ile Leu Arg Gly Arg Asn Ala Leu Asp Arg Leu Thr Arg Val Leu 180 185 190 Leu Thr Glu Ala Arg Ala His Trp Pro Gln Leu Trp Ala Thr Leu Ala 195 200 205 Pro Arg Pro Ile Ile Met Thr Ser Trp Val Gly Tyr Asp Thr Asp Gly 210 215 220 Arg Thr Asp Ile Gly Trp Trp Asp Thr Leu Arg Leu Arg Val Arg Met 225 230 235 240 Lys His Met Gln Leu Thr Arg Leu Asn Ala Gln Ile Gly Pro Val Ala 245 250 255 Ser Val Pro Asn Asp Leu His Glu Arg Val Asn Arg Ala Ile Gln Ala 260 265 270 Val Glu Ala Gln Ile Ala Ala Cys Pro Gly Ser Ala Asp Pro Gln Ala 275 280 285 Val Ala Asp Phe Ala Ala Val Leu Ile Gly Arg Arg Glu Glu Ala Met 290 295 300 Thr Ser Ser Asn Asp Leu Ala Pro Thr Phe Ala Glu Ala Ile Asp Ala 305 310 315 320 Ala Thr Leu Asp Asp Lys Met Thr Leu Ala Val Ala Arg Ala Gly Phe 325 330 335 Met Ala His Gly Leu Ser Ala Ala His Thr His Val Arg Leu Asn Ser 340 345 350 Thr Gln Leu His Asn Val Ala Arg Gln Arg Leu Gly Ile Thr Asp Asn 355 360 365 Pro Asp Ile His Ala Gln Arg Arg Ala Arg Ile Ala Arg Ile Asp Glu 370 375 380 Ala Leu Asp Thr Thr Gln Pro Ile Asp Ile Asp Phe Gly Ser Leu Leu 385 390 395 400 Val Glu Gln Ser Thr Ala Gly Arg Leu Met Met Thr Val Arg Gln Ile 405 410 415 Leu His His Ile Asp Arg Thr Thr Pro Ile Arg Phe Leu Ile Ala Glu 420 425 430 Thr Glu Thr Gly Tyr Thr Leu Leu Thr Ala Leu Trp Leu Ala Arg Leu 435 440 445 Leu Gly Val Glu Asp Met Ile Glu Ile Ser Pro Leu Phe Glu Thr Gln 450 455 460 Asp Ala Leu Glu Gln Gly Glu His Leu Ile Glu Glu Ala Leu His Ser 465 470 475 480 Pro His Trp Arg Ala Tyr Leu His Arg Thr Arg Lys Leu Ser Leu Gln 485 490 495 Phe Gly Phe Ser Asp Ser Gly Arg Tyr Val Gly Gln Leu Ala Ala Thr 500 505 510 Tyr Leu Ile Glu Arg Leu Arg Leu Lys Val Cys Asp Leu Leu Arg Gln 515 520 525 Trp Asp Leu Ala Phe Val Glu Val Ile Leu Phe Asp Thr His Gly Glu 530 535 540 Ser Ile Gly Arg Gly Ala His Pro Tyr Ser Leu Ala Glu Arg Phe Asp 545 550 555 560 Tyr Leu Ser Pro Pro His Ala Arg Met Arg Phe Leu Gln Ala Gly Ile 565 570 575 Arg Leu Arg Glu Glu Thr Ala Phe Gln Gly Gly Asp Gly Tyr Leu Leu 580 585 590 Phe Gly Thr Gln Pro Leu Ala Asp Ala Thr Val Ser Val Ile Ala Glu 595 600 605 His Ala Phe Ala Thr Thr Ser Ile Asp Glu Asp Pro Val Tyr Asp Glu 610 615 620 Pro Asp Phe Ser Ala Asp Phe Phe Ser Ala Ile Ala Arg Gly Met Thr 625 630 635 640 Gly Leu Val Glu Asp Pro Gly Tyr Ala Ala Leu Leu Gly Ala Phe Gly 645 650 655 Pro Ser Leu Ile Asp Lys Thr Gly Ser Arg Pro Ser Ala Arg Gln Ser 660 665 670 Asp Thr Ala Ala Ile Thr Thr Arg Ile Arg His Pro Ser Gln Leu Arg 675 680 685 Ala Ile Pro Asn Asn Ala Ile Leu Gln Gln Leu Gly Trp Cys Ala Asn 690 695 700 Thr Leu Gln Gly Leu Gly Thr Ala Ala Ala Arg His Pro Asp Thr Phe 705 710 715 720 720 Glu Arg Tyr Leu Asn Asp Ser Pro Arg Phe Arg Arg Ala Leu Asp Phe 725 730 735 Ala Ala His Gly Leu Ala His Ser Ser Asp Gly Val Leu Arg Gly Val 740 745 750 Ile Arg Leu Leu Asp Pro Asp Met Trp Leu Gln Arg Ala Thr Ala His 755 760 765 His Asp Pro Lys Arg Gln Asp Ala Cys Leu Thr Leu Met His Gly Leu 770 775 780 Glu Arg Leu Asp Phe Trp Ala Cys Thr Gln Ser Met Phe Arg Arg Leu 785 790 795 800 Gln Ser Asp His Leu Ala Leu Arg Asn Ala Trp Pro Ser Ala Pro Arg 805 810 815 Met Glu Ala Asp Glu Met Leu Leu His Ala Ile Arg Ile Ala Ile Ile 820 825 830 Glu Gln Ile Trp Met Leu Ser Thr Arg Ile Pro Tyr Phe Ala Pro Arg 835 840 845 Asn Ala Phe Thr Arg Asp Val Leu Thr Ala Lys Val Leu Cys Leu Glu 850 855 860 Ile Pro Asp Val Leu Lys Glu Leu Glu His Ile Phe Pro Tyr His Ala 865 870 875 880 Asp Arg Ser Phe Asp Leu Asp Phe His Glu Pro His Gly Pro Arg Asp 885 890 895 Glu Gly Thr Tyr Met Arg Glu Tyr Thr Glu Ile Phe Glu Pro Met Gln 900 905 910 Arg Leu Phe Thr Leu Val Arg Glu Ile Ser Thr Gly Val Met His His 915 920 925 Val Gly Ala Phe Gly 930 933
【0050】配列番号:2 配列の長さ:2802 配列の型:核酸(DNA) 鎖の数:ニ本鎖 トポロジー:直鎖状 配列の種類:genomicDNA 起源 生物名:アセトバクター・ハンゼニイ(Acetobacter ha
nsenii) 株名:IFO14820 配列 ATG TCC CAG GCC TCT GCC CCT CAT GCA ACA GAC ATG CTG CAG CAG CAG 48 Met Ser Gln Ala Ser Ala Pro His Ala Thr Asp Met Leu Gln Gln Gln 1 5 10 15 GCC CGC GAA CTT GTG GCG ATC CCT GCC CTT TCC GAC AAC CCG GTC ATG 96 Ala Arg Glu Leu Val Ala Ile Pro Ala Leu Ser Asp Asn Pro Val Met 20 25 30 ACG CTG GCA CGC AGC ATC GGA CAG CAG ATC GAC CGG GGC AGC CTG TCG 144 Thr Leu Ala Arg Ser Ile Gly Gln Gln Ile Asp Arg Gly Ser Leu Ser 35 40 45 ACC GAC GCG CTG GAG GCC TGG GTC CGC CGC CTG CGC GAC GCC GCG TTC 192 Thr Asp Ala Leu Glu Ala Trp Val Arg Arg Leu Arg Asp Ala Ala Phe 50 55 60 GCC CGC CGC GCC TGC CAT ATC GCC GCG TAT GTC GGG GGG GTG GAT GAT 240 Ala Arg Arg Ala Cys His Ile Ala Ala Tyr Val Gly Gly Val Asp Asp 65 70 75 80 GCC GTC ATC GAC CAG CGC ATG CGT GAC GTG GCG CGC CGC ATC ATG CAG 288 Ala Val Ile Asp Gln Arg Met Arg Asp Val Ala Arg Arg Ile Met Gln 85 90 95 CCC GAC CCA AAT GAC AGC CCG GTG CCC ATC GCC CGG TTC CGC GCC GCG 336 Pro Asp Pro Asn Asp Ser Pro Val Pro Ile Ala Arg Phe Arg Ala Ala 100 105 110 ACC GAA CGC AGC CGC TTT GCC GCC GTG TTC ACC GCG CAT CCC ACG TTT 384 Thr Glu Arg Ser Arg Phe Ala Ala Val Phe Thr Ala His Pro Thr Phe 115 120 125 GCG CTG GCC AGC CCC GTC TAT GAC TGC CTT GCC GAC ATG GCG ACG CAA 432 Ala Leu Ala Ser Pro Val Tyr Asp Cys Leu Ala Asp Met Ala Thr Gln 130 135 140 AAC CCG CAG CAG CCC CCG ACC GAT GTC CCG GCA TTC ATA ACG CAT CGC 480 Asn Pro Gln Gln Pro Pro Thr Asp Val Pro Ala Phe Ile Thr His Arg 145 150 155 160 CGC GCC GCG CCG CCG ACG CTG GAT GAG GAA TTC ACG CTG GCG ACG CAG 528 Arg Ala Ala Pro Pro Thr Leu Asp Glu Glu Phe Thr Leu Ala Thr Gln 165 170 175 GCG ATC CTG CGC GGG CGC AAT GCA CTC GAT CGC CTG ACG CGG GTT CTC 576 Ala Ile Leu Arg Gly Arg Asn Ala Leu Asp Arg Leu Thr Arg Val Leu 180 185 190 CTG ACC GAG GCA CGG GCA CAC TGG CCG CAA CTG TGG GCC ACG CTG GCG 624 Leu Thr Glu Ala Arg Ala His Trp Pro Gln Leu Trp Ala Thr Leu Ala 195 200 205 CCG CGT CCC ATT ATC ATG ACA AGC TGG GTC GGA TAC GAC ACG GAC GGA 672 Pro Arg Pro Ile Ile Met Thr Ser Trp Val Gly Tyr Asp Thr Asp Gly 210 215 220 CGC ACC GAT ATC GGG TGG TGG GAC ACG CTG CGG CTG CGC GTG CGC ATG 720 Arg Thr Asp Ile Gly Trp Trp Asp Thr Leu Arg Leu Arg Val Arg Met 225 230 235 240 AAG CAC ATG CAG TTA ACC CGC CTG AAT GCA CAG ATT GGC CCC GTC GCC 768 Lys His Met Gln Leu Thr Arg Leu Asn Ala Gln Ile Gly Pro Val Ala 245 250 255 TCC GTC CCC AAT GAC CTG CAC GAA CGC GTC AAT CGC GCC ATA CAG GCG 816 Ser Val Pro Asn Asp Leu His Glu Arg Val Asn Arg Ala Ile Gln Ala 260 265 270 GTG GAG GCA CAG ATC GCC GCA TGC CCC GGC AGT GCC GAC CCG CAG GCG 864 Val Glu Ala Gln Ile Ala Ala Cys Pro Gly Ser Ala Asp Pro Gln Ala 275 280 285 GTG GCC GAT TTT GCC GCG GTC CTG ATC GGT CGC CGC GAA GAG GCC ATG 912 Val Ala Asp Phe Ala Ala Val Leu Ile Gly Arg Arg Glu Glu Ala Met 290 295 300 ACC AGC AGC AAC GAC CTC GCC CCC ACT TTT GCC GAA GCC ATT GAT GCC 960 Thr Ser Ser Asn Asp Leu Ala Pro Thr Phe Ala Glu Ala Ile Asp Ala 305 310 315 320 GCG ACG CTG GAC GAC AAG ATG ACG CTG GCG GTC GCA CGC GCG GGT TTC 1008 Ala Thr Leu Asp Asp Lys Met Thr Leu Ala Val Ala Arg Ala Gly Phe 325 330 335 ATG GCC CAT GGC CTG TCG GCG GCG CAT ACG CAT GTA CGC CTC AAT TCC 1056 Met Ala His Gly Leu Ser Ala Ala His Thr His Val Arg Leu Asn Ser 340 345 350 ACG CAA TTA CAC AAT GTC GCC CGC CAG CGC CTG GGC ATT ACC GAC AAT 1104 Thr Gln Leu His Asn Val Ala Arg Gln Arg Leu Gly Ile Thr Asp Asn 355 360 365 CCC GAT ATC CAT GCC CAG CGT CGC GCC CGG ATC GCA CGC ATT GAC GAG 1152 Pro Asp Ile His Ala Gln Arg Arg Ala Arg Ile Ala Arg Ile Asp Glu 370 375 380 GCG CTG GAT ACA ACG CAG CCA ATC GAC ATT GAT TTC GGC TCC CTG CTG 1200 Ala Leu Asp Thr Thr Gln Pro Ile Asp Ile Asp Phe Gly Ser Leu Leu 385 390 395 400 GTG GAA CAG TCA ACG GCG GGG CGG CTG ATG ATG ACG GTG CGC CAG ATC 1248 Val Glu Gln Ser Thr Ala Gly Arg Leu Met Met Thr Val Arg Gln Ile 405 410 415 CTG CAC CAT ATC GAC CGC ACC ACG CCC ATC CGT TTC CTG ATC GCG GAA 1296 Leu His His Ile Asp Arg Thr Thr Pro Ile Arg Phe Leu Ile Ala Glu 420 425 430 ACG GAA ACC GGC TAT ACG CTG CTG ACG GCA CTG TGG CTT GCG CGC CTG 1344 Thr Glu Thr Gly Tyr Thr Leu Leu Thr Ala Leu Trp Leu Ala Arg Leu 435 440 445 CTG GGC GTG GAA GAC ATG ATC GAA ATC TCC CCC CTG TTT GAA ACG CAG 1392 Leu Gly Val Glu Asp Met Ile Glu Ile Ser Pro Leu Phe Glu Thr Gln 450 455 460 GAC GCG CTG GAA CAG GGG GAA CAC CTG ATC GAA GAA GCG CTG CAT TCA 1440 Asp Ala Leu Glu Gln Gly Glu His Leu Ile Glu Glu Ala Leu His Ser 465 470 475 480 CCG CAC TGG CGC GCC TAC CTG CAT CGT ACG CGC AAG CTG AGC CTG CAA 1488 Pro His Trp Arg Ala Tyr Leu His Arg Thr Arg Lys Leu Ser Leu Gln 485 490 495 TTC GGT TTT TCG GAT TCG GGA CGT TAT GTG GGA CAG CTT GCC GCG ACC 1536 Phe Gly Phe Ser Asp Ser Gly Arg Tyr Val Gly Gln Leu Ala Ala Thr 500 505 510 TAC CTG ATC GAA CGG CTG CGG CTG AAG GTC TGC GAC CTT CTG CGG CAA 1584 Tyr Leu Ile Glu Arg Leu Arg Leu Lys Val Cys Asp Leu Leu Arg Gln 515 520 525 TGG GAC CTC GCC TTC GTG GAA GTC ATC CTG TTC GAC ACC CAT GGG GAA 1632 Trp Asp Leu Ala Phe Val Glu Val Ile Leu Phe Asp Thr His Gly Glu 530 535 540 AGC ATC GGC CGC GGG GCA CAT CCC TAC AGC CTT GCC GAA CGT TTC GAC 1680 Ser Ile Gly Arg Gly Ala His Pro Tyr Ser Leu Ala Glu Arg Phe Asp 545 550 555 560 TAT CTC TCC CCC CCG CAT GCG CGC ATG CGT TTC CTG CAG GCA GGC ATT 1728 Tyr Leu Ser Pro Pro His Ala Arg Met Arg Phe Leu Gln Ala Gly Ile 565 570 575 CGC CTG CGC GAG GAA ACG GCC TTT CAG GGG GGG GAT GGC TAC CTC CTG 1776 Arg Leu Arg Glu Glu Thr Ala Phe Gln Gly Gly Asp Gly Tyr Leu Leu 580 585 590 TTC GGG ACG CAG CCC CTT GCG GAT GCA ACT GTC AGC GTG ATC GCG GAA 1824 Phe Gly Thr Gln Pro Leu Ala Asp Ala Thr Val Ser Val Ile Ala Glu 595 600 605 CAC GCC TTT GCC ACG ACC TCC ATC GAC GAA GAC CCG GTT TAC GAC GAA 1872 His Ala Phe Ala Thr Thr Ser Ile Asp Glu Asp Pro Val Tyr Asp Glu 610 615 620 CCC GAT TTC TCT GCC GAT TTC TTT TCC GCC ATC GCG CGC GGC ATG ACA 1920 Pro Asp Phe Ser Ala Asp Phe Phe Ser Ala Ile Ala Arg Gly Met Thr 625 630 635 640 GGA CTG GTG GAG GAT CCA GGC TAT GCC GCG CTG CTG GGT GCG TTC GGG 1968 Gly Leu Val Glu Asp Pro Gly Tyr Ala Ala Leu Leu Gly Ala Phe Gly 645 650 655 CCG TCA CTA ATC GAC AAG ACG GGT TCA CGC CCC TCC GCC CGG CAG AGC 2016 Pro Ser Leu Ile Asp Lys Thr Gly Ser Arg Pro Ser Ala Arg Gln Ser 660 665 670 GAT ACG GCC GCC ATC ACC ACG CGC ATC CGC CAT CCC AGC CAG TTG CGC 2064 Asp Thr Ala Ala Ile Thr Thr Arg Ile Arg His Pro Ser Gln Leu Arg 675 680 685 GCC ATC CCC AAC AAC GCC ATC CTC CAG CAG CTT GGC TGG TGC GCC AAT 2112 Ala Ile Pro Asn Asn Ala Ile Leu Gln Gln Leu Gly Trp Cys Ala Asn 690 695 700 ACG TTG CAG GGG CTG GGC ACG GCG GCC GCG CGT CAT CCC GAT ACG TTC 2160 Thr Leu Gln Gly Leu Gly Thr Ala Ala Ala Arg His Pro Asp Thr Phe 705 710 715 720 Glu Arg Tyr Leu Asn Asp Ser Pro Arg Phe Arg Arg Ala Leu Asp Phe 725 730 735 GCC GCC CAT GGC CTG GCC CAT TCC AGC GAC GGC GTC CTG CGT GGT GTG 2256 Ala Ala His Gly Leu Ala His Ser Ser Asp Gly Val Leu Arg Gly Val 740 745 750 ATC CGG CTG CTG GAC CCG GAC ATG TGG TTG CAA CGC GCA ACG GCG CAT 2304 Ile Arg Leu Leu Asp Pro Asp Met Trp Leu Gln Arg Ala Thr Ala His 755 760 765 CAC GAC CCG AAA CGG CAG GAT GCG TGC CTG ACG CTG ATG CAC GGG CTG 2352 His Asp Pro Lys Arg Gln Asp Ala Cys Leu Thr Leu Met His Gly Leu 770 775 780 GAA CGG CTG GAT TTC TGG GCC TGT ACG CAA TCC ATG TTC CGC CGC CTG 2400 Glu Arg Leu Asp Phe Trp Ala Cys Thr Gln Ser Met Phe Arg Arg Leu 785 790 795 800 CAA TCG GAC CAT CTG GCG TTA CGC AAC GCA TGG CCC AGC GCA CCA CGG 2448 Gln Ser Asp His Leu Ala Leu Arg Asn Ala Trp Pro Ser Ala Pro Arg 805 810 815 ATG GAG GCG GAT GAA ATG CTG CTG CAT GCC ATC CGC ATC GCC ATC ATT 2496 Met Glu Ala Asp Glu Met Leu Leu His Ala Ile Arg Ile Ala Ile Ile 820 825 830 GAA CAG ATA TGG ATG CTG TCC ACC CGG ATC CCG TAT TTT GCG CCG CGC 2544 Glu Gln Ile Trp Met Leu Ser Thr Arg Ile Pro Tyr Phe Ala Pro Arg 835 840 845 AAT GCG TTC ACC CGC GAC GTG CTG ACG GCG AAG GTC CTG TGC CTG GAA 2592 Asn Ala Phe Thr Arg Asp Val Leu Thr Ala Lys Val Leu Cys Leu Glu 850 855 860 ATC CCC GAT GTG CTG AAG GAG CTG GAG CAT ATC TTC CCC TAT CAC GCG 2640 Ile Pro Asp Val Leu Lys Glu Leu Glu His Ile Phe Pro Tyr His Ala 865 870 875 880 GAC CGC AGC TTC GAC CTG GAT TTC CAT GAA CCG CAC GGG CCC CGC GAT 2688 Asp Arg Ser Phe Asp Leu Asp Phe His Glu Pro His Gly Pro Arg Asp 885 890 895 GAA GGG ACG TAT ATG CGC GAA TAC ACG GAA ATT TTC GAA CCG ATG CAA 2736 Glu Gly Thr Tyr Met Arg Glu Tyr Thr Glu Ile Phe Glu Pro Met Gln 900 905 910 CGG CTG TTC ACA CTG GTG CGC GAA ATC AGC ACC GGC GTG ATG CAC CAT 2784 Arg Leu Phe Thr Leu Val Arg Glu Ile Ser Thr Gly Val Met His His 915 920 925 GTC GGG GCC TTT GGC TGA 2802 Val Gly Ala Phe Gly *** 930 933SEQ ID NO: 2 Sequence length: 2802 Sequence type: Nucleic acid (DNA) Number of strands: Double strand Topology: Linear Sequence type: GenomicDNA Origin Biological name: Acetobacter hazenii
nsenii) Strain name: IFO14820 Sequence ATG TCC CAG GCC TCT GCC CCT CAT GCA ACA GAC ATG CTG CAG CAG CAG 48 Met Ser Gln Ala Ser Ala Pro His Ala Thr Asp Met Leu Gln Gln Gln 1 5 10 15 GCC CGC GAA CTT GTG GCG ATC CCT GCC CTT TCC GAC AAC CCG GTC ATG 96 Ala Arg Glu Leu Val Ala Ile Pro Ala Leu Ser Asp Asn Pro Val Met 20 25 30 ACG CTG GCA CGC AGC ATC GGA CAG CAG ATC GAC CGG GGC AGC CTG TCG 144 Thr Leu Ala Arg Ser Ile Gly Gln Gln Ile Asp Arg Gly Ser Leu Ser 35 40 45 ACC GAC GCG CTG GAG GCC TGG GTC CGC CGC CTG CGC GAC GCC GCG TTC 192 Thr Asp Ala Leu Glu Ala Trp Val Arg Arg Leu Arg Asp Ala Ala Phe 50 55 60 GCC CGC CGC GCC TGC CAT ATC GCC GCG TAT GTC GGG GGG GTG GAT GAT 240 Ala Arg Arg Ala Cys His Ile Ala Ala Tyr Val Gly Gly Val Asp Asp 65 70 75 80 GCC GTC ATC GAC CAG CGC ATG CGT GAC GTG GCG CGC CGC ATC ATG CAG 288 Ala Val Ile Asp Gln Arg Met Arg Asp Val Ala Arg Arg Ile Met Gln 85 90 95 CCC GAC CCA AAT GAC AGC CCG GTG CCC ATC GCC CGG TTC CGC GCC GCG 336 Pro Asp Pro Asn Asp Ser Pro Val P ro Ile Ala Arg Phe Arg Ala Ala 100 105 110 ACC GAA CGC AGC CGC TTT GCC GCC GTG TTC ACC GCG CAT CCC ACG TTT 384 Thr Glu Arg Ser Arg Phe Ala Ala Val Phe Thr Ala His Pro Thr Phe 115 120 125 GCG CTG GCC AGC CCC GTC TAT GAC TGC CTT GCC GAC ATG GCG ACG CAA 432 Ala Leu Ala Ser Pro Val Tyr Asp Cys Leu Ala Asp Met Ala Thr Gln 130 135 140 AAC CCG CAG CAG CCC CCG ACC GAT GTC CCG GCA TTC ATA ACG CAT CGC 480 Asn Pro Gln Gln Pro Pro Thr Asp Val Pro Ala Phe Ile Thr His Arg 145 150 155 160 CGC GCC GCG CCG CCG ACG CTG GAT GAG GAA TTC ACG CTG GCG ACG CAG 528 Arg Ala Ala Pro Pro Thr Leu Asp Glu Glu Phe Thr Leu Ala Thr Gln 165 170 175 GCG ATC CTG CGC GGG CGC AAT GCA CTC GAT CGC CTG ACG CGG GTT CTC 576 Ala Ile Leu Arg Gly Arg Asn Ala Leu Asp Arg Leu Thr Arg Val Leu 180 185 190 CTG ACC GAG GCA CGG GCA CAC TGG CCG CAA CTG TGG GCC ACG CTG GCG 624 Leu Thr Glu Ala Arg Ala His Trp Pro Gln Leu Trp Ala Thr Leu Ala 195 200 205 CCG CGT CCC ATT ATC ATG ACA AGC TGG GTC GGA TAC GAC ACG GAC GGA 672 Pro Arg Pro Ile Ile M et Thr Ser Trp Val Gly Tyr Asp Thr Asp Gly 210 215 220 CGC ACC GAT ATC GGG TGG TGG GAC ACG CTG CGG CTG CGC GTG CGC ATG 720 Arg Thr Asp Ile Gly Trp Trp Asp Thr Leu Arg Leu Arg Val Arg Met 225 230 235 240 AAG CAC ATG CAG TTA ACC CGC CTG AAT GCA CAG ATT GGC CCC GTC GCC 768 Lys His Met Gln Leu Thr Arg Leu Asn Ala Gln Ile Gly Pro Val Ala 245 250 255 TCC GTC CCC AAT GAC CTG CAC GAA CGC GTC AAT CGC GCC ATA CAG GCG 816 Ser Val Pro Asn Asp Leu His Glu Arg Val Asn Arg Ala Ile Gln Ala 260 265 270 GTG GAG GCA CAG ATC GCC GCA TGC CCC GGC AGT GCC GAC CCG CAG GCG 864 Val Glu Ala Gln Ile Ala Ala Cys Pro Gly Ser Ala Asp Pro Gln Ala 275 280 285 GTG GCC GAT TTT GCC GCG GTC CTG ATC GGT CGC CGC GAA GAG GCC ATG 912 Val Ala Asp Phe Ala Ala Val Leu Ile Gly Arg Arg Glu Glu Ala Met 290 295 300 ACC AGC AGC AAC GAC CTC GCC CCC ACT TTT GCC GAA GCC ATT GAT GCC 960 Thr Ser Ser Asn Asp Leu Ala Pro Thr Phe Ala Glu Ala Ile Asp Ala 305 310 315 320 GCG ACG CTG GAC GAC AAG ATG ACG CTG GCG GTC GCA CGC GCG GGT TTC 1008 Ala Thr Leu Asp Asp Lys Met Thr Leu Ala Val Ala Arg Ala Gly Phe 325 330 335 ATG GCC CAT GGC CTG TCG GCG GCG CAT ACG CAT GTA CGC CTC AAT TCC 1056 Met Ala His Gly Leu Ser Ala Ala His Thr His Val Arg Leu Asn Ser 340 345 350 ACG CAA TTA CAC AAT GTC GCC CGC CAG CGC CTG GGC ATT ACC ACC GAC AAT 1104 Thr Gln Leu His Asn Val Ala Arg Gln Arg Leu Gly Ile Thr Asp Asn 355 360 365 CCC GAT ATC CAT GCC CAG CGT CGC GCC CGG ATC GCA CGC ATT GAC GAG 1152 Pro Asp Ile His Ala Gln Arg Arg Ala Arg Ile Ala Arg Ile Asp Glu 370 375 380 GCG CTG GAT ACA ACG CAG CCA ATC GAC ATT GAT TTC GGC TCC CTG CTG 1200 Ala Leu Asp Thr Thr Gln Pro Ile Asp Ile Asp Phe Gly Ser Leu Leu 385 390 395 400 GTG GAA CAG TCA ACG GCG GGG CGG CTG ATG ATG ACG GTG CGC CAG ATC 1248 Val Glu Gln Ser Thr Ala Gly Arg Leu Met Met Thr Val Arg Gln Ile 405 410 415 CTG CAC CAT ATC GAC CGC ACC ACG CCC ATC CGT TTC CTG ATC GCG GAA 1296 Leu His His Ile Asp Arg Thr Thr Pro Ile Arg Phe Leu Ile Ala Glu 420 425 430 ACG GAA ACC GGC TAT ACG CTG CTG ACG GCA CTG TGG CTT GC G CGC CTG 1344 Thr Glu Thr Gly Tyr Thr Leu Leu Thr Ala Leu Trp Leu Ala Arg Leu 435 440 445 CTG GGC GTG GAA GAC ATG ATC GAA ATC TCC CCC CTG TTT GAA ACG CAG 1392 Leu Gly Val Glu Asp Met Ile Glu Ile Ser Pro Leu Phe Glu Thr Gln 450 455 460 GAC GCG CTG GAA CAG GGG GAA CAC CTG ATC GAA GAA GCG CTG CAT TCA 1440 Asp Ala Leu Glu Gln Gly Glu His Leu Ile Glu Glu Ala Leu His Ser 465 470 475 480 CCG CAC TGG CGC GCC TAC CTG CAT CGT ACG CGC AAG CTG AGC CTG CAA 1488 Pro His Trp Arg Ala Tyr Leu His Arg Thr Arg Lys Leu Ser Leu Gln 485 490 495 TTC GGT TTT TCG GAT TCG GGA CGT TAT GTG GGA CAG CTT GCC GCG ACC 1536 Phe Gly Phe Ser Asp Ser Gly Arg Tyr Val Gly Gln Leu Ala Ala Thr 500 505 510 TAC CTG ATC GAA CGG CTG CGG CTG AAG GTC TGC GAC CTT CTG CGG CAA 1584 Tyr Leu Ile Glu Arg Leu Arg Leu Lys Val Cys Asp Leu Leu Arg Gln 515 520 525 TGG GAC CTC GCC TTC GTG GAA GTC ATC CTG TTC GAC ACC CAT GGG GAA 1632 Trp Asp Leu Ala Phe Val Glu Val Ile Leu Phe Asp Thr His Gly Glu 530 535 540 AGC ATC GGC CGC GGG GCA CAT CCC TAC AGC CTT GCC GAA CGT TTC GAC 1680 Ser Ile Gly Arg Gly Ala His Pro Tyr Ser Leu Ala Glu Arg Phe Asp 545 550 555 560 TAT CTC TCC CCC CCG CAT GCG CGC ATG CGT TTC CTG CAG GCA GGC ATT 1728 Tyr Leu Ser Pro Pro His Ala Arg Met Arg Phe Leu Gln Ala Gly Ile 565 570 575 CGC CTG CGC GAG GAA ACG GCC TTT CAG GGG GGG GAT GGC TAC CTC CTG 1776 Arg Leu Arg Glu Glu Thr Ala Phe Gln Gly Gly Asp Gly Tyr Leu Leu 580 585 TTC GGG ACG CAG CCC CTT GCG GAT GCA ACT GTC AGC GTG ATC GCG GAA 1824 Phe Gly Thr Gln Pro Leu Ala Asp Ala Thr Val Ser Val Ile Ala Glu 595 600 605 CAC GCC TTT GCC ACG ACC TCC ATC GAC GAA GAC CCG GTT TAC GAC GAA 1872 His Ala Phe Ala Thr Thr Ser Ile Asp Glu Asp Pro Val Tyr Asp Glu 610 615 620 CCC GAT TTC TCT GCC GAT TTC TTT TCC GCC ATC GCG CGC GGC ATG ACA 1920 Pro Asp Phe Ser Ala Asp Phe Phe Ser Ala Ile Ala Arg Gly Met Thr 625 630 635 640 GGA CTG GTG GAG GAT CCA GGC TAT GCC GCG CTG CTG GGT GCG TTC GGG 1968 Gly Leu Val Glu Asp Pro Gly Tyr Ala Ala Leu Leu Gly Ala Phe Gly 645 650 655 CCG TCA CTA ATC GAC AAG ACG GGT TCA CGC CCC TCC GCC CGG CAG AGC 2016 Pro Ser Leu Ile Asp Lys Thr Gly Ser Arg Pro Ser Ala Arg Gln Ser 660 665 670 GAT ACG GCC GCC ATC ACC ACG CGC ATC CGC CAT CCC AGC CAG TTG CGC 2064 Asp Thr Ala Ala Ile Thr Thr Arg Ile Arg His Pro Ser Gln Leu Arg 675 680 685 GCC ATC CCC AAC AAC GCC ATC CTC CAG CAG CTT GGC TGG TGC GCC AAT 2112 Ala Ile Pro Asn Asn Ala Ile Leu Gln Gln Leu Gly Trp Cys Ala Asn 690 695 700 ACG TTG CAG GGG CTG GGC ACG GCG GCC GCG CGT CAT CCC GAT ACG TTC 2160 Thr Leu Gln Gly Leu Gly Thr Ala Ala Ala Arg His Pro Asp Thr Phe 705 710 715 720 Glu Arg Tyr Leu Asn Asp Ser Pro Arg Phe Arg Arg Ala Leu Asp Phe 725 730 735 GCC GCC CAT GGC CTG GCC CAT TCC AGC GAC GGC GTC CTG CGT GGT GTG 2256 Ala Ala His Gly Leu Ala His Ser Ser Asp Gly Val Leu Arg Gly Val 740 745 750 ATC CGG CTG CTG GAC CCG GAC ATG TGG TTG CAA CGC GCA ACG GCG CAT 2304 Ile Arg Leu Leu Asp Pro Asp Met Trp Leu Gln Arg Ala Thr Ala His 755 760 765 CAC GAC CCG AAA CGG CAG GAT GCG TGC CTG ACG CTG ATG CAC GGG CT G 2352 His Asp Pro Lys Arg Gln Asp Ala Cys Leu Thr Leu Met His Gly Leu 770 775 780 GAA CGG CTG GAT TTC TGG GCC TGT ACG CAA TCC ATG TTC CGC CGC CTG 2400 Glu Arg Leu Asp Phe Trp Ala Cys Thr Gln Ser Met Phe Arg Arg Leu 785 790 795 800 CAA TCG GAC CAT CTG GCG TTA CGC AAC GCA TGG CCC AGC GCA CCA CGG 2448 Gln Ser Asp His Leu Ala Leu Arg Asn Ala Trp Pro Ser Ala Pro Arg 805 810 815 ATG GAG GCG GAT GAA ATG CTG CTG CAT GCC ATC CGC ATC GCC ATC ATT 2496 Met Glu Ala Asp Glu Met Leu Leu His Ala Ile Arg Ile Ala Ile Ile 820 825 830 GAA CAG ATA TGG ATG CTG TCC ACC CGG ATC CCG TAT TTT GCG CCG CGC 2544 Glu Gln Glu Trp Met Leu Ser Thr Arg Ile Pro Tyr Phe Ala Pro Arg 835 840 845 AAT GCG TTC ACC CGC GAC GTG CTG ACG GCG AAG GTC CTG TGC CTG GAA 2592 Asn Ala Phe Thr Arg Asp Val Leu Thr Ala Lys Val Leu Cys Leu Glu 850 855 860 ATC CCC GAT GTG CTG AAG GAG CTG GAG CAT ATC TTC CCC TAT CAC GCG 2640 Ile Pro Asp Val Leu Lys Glu Leu Glu His Ile Phe Pro Tyr His Ala 865 870 875 880 GAC CGC AGC TTC GAC CTG GAT TTC CAT GAA CCG CAC GGG CCC CGC GAT 2688 Asp Arg Ser Phe Asp Leu Asp Phe His Glu Pro His Gly Pro Arg Asp 885 890 895 GAA GGG ACG TAT ATG CGC GAA TAC ACG GAA ATT TTC GAA CCG ATG CAA 2736 Glu Gly Thr Tyr Met Arg Glu Tyr Thr Glu Ile Phe Glu Pro Met Gln 900 905 910 CGG CTG TTC ACA CTG GTG CGC GAA ATC AGC ACC GGC GTG ATG CAC CAT 2784 Arg Leu Phe Thr Leu Val Arg Glu Ile Ser Thr Gly Val Met His His 915 920 925 GTC GGG GCC TTT GGC TGA 2802 Val Gly Ala Phe Gly *** 930 933
【図1】重炭酸イオン濃度と吸光度変化の関係を示す。FIG. 1 shows the relationship between bicarbonate ion concentration and absorbance change.
【図2】炭酸ガス測定用試液中の安定性を示す。FIG. 2 shows the stability in a test solution for measuring carbon dioxide.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 //(C12N 9/00 C12R 1:19) (C12N 1/21 C12R 1:19) (72)発明者 山本 和巳 福井県敦賀市東洋町10番24号 東洋紡績株 式会社敦賀バイオ研究所内 (72)発明者 川村 良久 福井県敦賀市東洋町10番24号 東洋紡績株 式会社敦賀バイオ研究所内─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 6 Identification code Internal reference number FI technical display location // (C12N 9/00 C12R 1:19) (C12N 1/21 C12R 1:19) (72) Inventor Kazumi Yamamoto 10-24 Toyo-cho, Tsuruga-shi, Fukui Prefecture Toyobo Co., Ltd. in the Tsuruga Bio Research Laboratory (72) Inventor Yoshihisa Kawamura 10-24 Toyo-cho, Tsuruga-city, Fukui Toyobo Co., Ltd.
Claims (6)
酸配列をコードするDNAを含有することを特徴とする
ホスホエノールピルビン酸カルボキシラーゼをコードす
るDNA断片。1. A DNA fragment encoding phosphoenolpyruvate carboxylase, which comprises a DNA encoding the amino acid sequence set forth in SEQ ID NO: 1 of the Sequence Listing.
列を含有することを特徴とする請求項1記載のホスホエ
ノールピルビン酸カルボキシラーゼをコードするDNA
断片。2. A DNA encoding phosphoenolpyruvate carboxylase according to claim 1, which contains the nucleotide sequence shown in Sequence Listing / SEQ ID NO: 2.
fragment.
変異によって変化させられた、ホスホエノールピルビン
酸カルボキシラーゼ活性を有するポリペプチドをコード
することを特徴とするホスホエノールピルビン酸カルボ
キシラーゼをコードするDNA断片。3. A DNA encoding phosphoenolpyruvate carboxylase, characterized in that it encodes a polypeptide having phosphoenolpyruvate carboxylase activity which has been altered by mutation to the DNA sequence according to claim 2. fragment.
片を含有する組換えベクター。4. A recombinant vector containing the DNA fragment according to claim 2 or 3.
より形質転換された形質転換体。5. A transformant transformed with the recombinant vector according to claim 4.
で培養し、ホスホエノールピルビン酸カルボキシラーゼ
を生成させ、該ホスホエノールピルビン酸カルボキシラ
ーゼを採取することを特徴とするホスホエノールピルビ
ン酸カルボキシラーゼの製造法。6. A phosphoenolpyruvate carboxylase, which comprises culturing the transformant according to claim 5 in a medium to produce phosphoenolpyruvate carboxylase and collecting the phosphoenolpyruvate carboxylase. Manufacturing method.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP27133894A JP3396740B2 (en) | 1994-11-04 | 1994-11-04 | Gene encoding phosphoenolpyruvate carboxylase |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP27133894A JP3396740B2 (en) | 1994-11-04 | 1994-11-04 | Gene encoding phosphoenolpyruvate carboxylase |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2002048413A Division JP2002325591A (en) | 2002-02-25 | 2002-02-25 | Gene encoding phosphoenolpyruvate carboxylase |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH08131162A true JPH08131162A (en) | 1996-05-28 |
JP3396740B2 JP3396740B2 (en) | 2003-04-14 |
Family
ID=17498673
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP27133894A Expired - Lifetime JP3396740B2 (en) | 1994-11-04 | 1994-11-04 | Gene encoding phosphoenolpyruvate carboxylase |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3396740B2 (en) |
-
1994
- 1994-11-04 JP JP27133894A patent/JP3396740B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP3396740B2 (en) | 2003-04-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2001505041A (en) | Production of 1,3-propanediol from glycerol by recombinant bacteria expressing recombinant diol dehydratase | |
US5888786A (en) | Method for producing 2-keto-L-gulonic acid | |
CA2365092A1 (en) | Sorbitol dehydrogenase, gene encoding the same and use thereof | |
US5250415A (en) | Process for the preparation of glucose dehydrogenase from Bacillus megaterium | |
JP3396740B2 (en) | Gene encoding phosphoenolpyruvate carboxylase | |
US6716609B2 (en) | Polypeptides having α-hydroxy-γ-carboxymuconic acid-ε-semialdehyde dehydrogenase activity | |
JPH06303981A (en) | Dna having genetic information on protein having formaldehyde dehydrogenase activity and production of formaldehyde dehydrogenase | |
US5686294A (en) | Protein having heat-resistant malate dehydrogenase activity | |
JPH08131194A (en) | Measurement of carbonic acid gas and its reagent | |
JP3508871B2 (en) | DNA having genetic information of protein having creatinine deiminase activity and method for producing creatinine deiminase | |
HU215231B (en) | Genetechnologic process for producing s-/+/-2,2-dimethylcyclopropanecarboxamide by micro-organism | |
JPH10262674A (en) | Gene coding for alkaline phosphatase | |
JP2002325591A (en) | Gene encoding phosphoenolpyruvate carboxylase | |
JP3829950B2 (en) | Novel creatinine amide hydrolase | |
JP2706223B2 (en) | Use of DNA having genetic information of pyruvate oxidase | |
JP3358686B2 (en) | Gene encoding novel glutamate dehydrogenase and method for producing glutamate dehydrogenase using the gene | |
JP4161236B2 (en) | Novel L-α-glycerophosphate oxidase and method for producing the same | |
JP3018092B2 (en) | Gene of sarcosine oxidase from actinomycetes and its use | |
JP3803832B2 (en) | Gene encoding creatine amidinohydrolase | |
JP4405627B2 (en) | Novel polypeptide, DNA encoding the polypeptide, and uses thereof | |
US5043279A (en) | DNA encoding a bacillus creatinase | |
JPH08238087A (en) | Sarcosine oxidase and its production | |
JP4066203B2 (en) | Novel creatinine amide hydrolase | |
JPH07163341A (en) | Stabilized and modified protein | |
JP4161232B2 (en) | Novel protein having sarcosine oxidase activity and method for producing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080214 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090214 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090214 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100214 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100214 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110214 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110214 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120214 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130214 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130214 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140214 Year of fee payment: 11 |
|
EXPY | Cancellation because of completion of term |